Agency for Science, Technology and Research

Singapore

Back to Profile

1-100 of 3,512 for Agency for Science, Technology and Research Sort by
Query
Aggregations
IP Type
        Patent 3,509
        Trademark 3
Jurisdiction
        World 2,553
        United States 930
        Canada 29
Date
New (last 4 weeks) 13
2024 March (MTD) 7
2024 February 18
2024 January 19
2023 December 7
See more
IPC Class
A61P 35/00 - Antineoplastic agents 187
C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids 147
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum 88
G01N 33/50 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing 74
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons 62
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 2
05 - Pharmaceutical, veterinary and sanitary products 2
10 - Medical apparatus and instruments 2
35 - Advertising and business services 1
36 - Financial, insurance and real estate services 1
Status
Pending 299
Registered / In Force 3,213
  1     2     3     ...     36        Next Page

1.

LITHIUM BATTERY ELECTROLYTE

      
Application Number 18266258
Status Pending
Filing Date 2021-12-02
First Publication Date 2024-03-21
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Ding, Ning
  • Yin, Xuesong

Abstract

The present invention relates to an electrolyte comprising lithium difluoro(oxalate)borate (LiDFOB) and a carbonate solvent, wherein LiDFOB is present at a concentration in the range of 1.5 M to 3 M, a rechargeable battery comprising the electrolyte as described herein, a cathode layer, an anode layer and a separator, and a method of preparing the electrolyte as described herein, comprising the step of dissolving LiDFOB in a carbonate solvent, wherein LiDFOB is present at a concentration in the range of 1.5 M to 3 M.

IPC Classes  ?

  • H01M 10/0568 - Liquid materials characterised by the solutes
  • H01M 10/0525 - Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodes; Lithium-ion batteries
  • H01M 10/0569 - Liquid materials characterised by the solvents

2.

METHOD OF MONITORING MESENCHIMAL STEM CELL (MSC) POTENCY AND IMPROVING MSC DIFFERENTIATION POTENTIAL

      
Application Number SG2023050457
Publication Number 2024/058710
Status In Force
Filing Date 2023-06-28
Publication Date 2024-03-21
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Liu, Tongming
  • Simon, Cool

Abstract

Disclosed herein are a method of identifying therapeutically potent mesenchymal stem cells (MSCs) and a method of distinguishing MSCs from human fibroblasts, comprising detecting HOXA9 expression in the cell. Also disclosed is a method of treating diseases in a subject in need of MSCs, comprising modifying MSCs to overexpress HOXA9 and administering the modified MSCs to the subject in need.

IPC Classes  ?

  • G01N 33/68 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • C12N 5/0775 - Mesenchymal stem cells; Adipose-tissue derived stem cells
  • A61K 35/28 - Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
  • A61P 19/00 - Drugs for skeletal disorders

3.

PHOSPHORUS COMPOUNDS AND METHODS THEREOF

      
Application Number 18267416
Status Pending
Filing Date 2021-12-14
First Publication Date 2024-03-14
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Van Meurs, Martin
  • Nobbs, James David
  • Sugiarto, Sigit

Abstract

The disclosure concerns phosphorus compounds of formula (I), (II) and (III) and methods of synthesising these compounds. The phosphorus compound can be a cyclic phosphorus compound. The method comprises reacting a compound having two Michael acceptor groups with a hypophosphite ester, acid, salt or solvate thereof and an optional organosilicon compound. The diene can be a cyclodiene. The disclosure concerns phosphorus compounds of formula (I), (II) and (III) and methods of synthesising these compounds. The phosphorus compound can be a cyclic phosphorus compound. The method comprises reacting a compound having two Michael acceptor groups with a hypophosphite ester, acid, salt or solvate thereof and an optional organosilicon compound. The diene can be a cyclodiene.

IPC Classes  ?

  • C07F 9/6568 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
  • C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System

4.

A HAND-HELD PROBE FOR A RAMEN SPECTROSCOPY SYSTEM AND A RAMEN SPECTROSCOPY SYSTEM

      
Application Number SG2023050589
Publication Number 2024/054154
Status In Force
Filing Date 2023-08-29
Publication Date 2024-03-14
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Olivo, Malini
  • Bi, Renzhe
  • Zhang, Ruochong
  • Qi, Yi
  • Rajarahm, Poongkulali

Abstract

In some aspects, a hand-held probe for a Raman spectroscopy system is provided. The hand-held probe includes an excitation module, configured to emit a light beam along a light path; a beam splitter, oriented to reflect the light beam along the observation axis; an objective module, configured to receive the reflected light beam and transmit the reflected light beam to an object so as to generate a scattered light beam by the object, and configured to receive and transmit the scattered light beam to the beam splitter; a focusing mirror, configured to focus the refracted light beam from the beam splitter to a focus so as to generate a focused light beam; and an emission module, disposed at the focus and configured to receive the focused light beam, wherein the emission module is disposed at a same side as the excitation module with respect to the observation axis.

IPC Classes  ?

  • G01J 3/02 - Spectrometry; Spectrophotometry; Monochromators; Measuring colours - Details
  • G01J 3/44 - Raman spectrometry; Scattering spectrometry
  • A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
  • G01N 21/65 - Raman scattering

5.

METHOD OF INHIBITING DUROTAXIS AND/OR TREATING FIBROSIS

      
Application Number SG2023050603
Publication Number 2024/054155
Status In Force
Filing Date 2023-09-05
Publication Date 2024-03-14
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Lee, Yin Loon
  • Burke, Brian, Edmund
  • Chiam, Keng Hwee
  • Jun, Myeongjun
  • Stewart, Colin
  • Wong, Xianrong
  • Raghavan, Srikala
  • Banerjee, Avinanda
  • Ng, Krystle, Joy

Abstract

The present invention relates to cell biology. In particular, the present invention teaches methods of contacting the cells with a LING complex inhibitor to inhibit durotaxis and, in consequence, reduce fibrosis and metastasis. Methods of treating wound healing are also disclosed herein.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
  • A61P 11/16 - Central respiratory analeptics
  • A61P 3/04 - Anorexiants; Antiobesity agents
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

6.

A METHOD OF DETECTING THE PRESENCE OF A NUCLEIC ACID

      
Application Number SG2023050602
Publication Number 2024/049358
Status In Force
Filing Date 2023-08-31
Publication Date 2024-03-07
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Hirao, Ichiro
  • Hirao, Michiko

Abstract

There is provided a method detecting the presence of a nucleic acid in a sample, the method comprises performing an amplification reaction on the sample in the presence of a proofreading polymerase and a primer with a 2'-sugar modification. Also provided is a method of identifying a disease in subject and a kit for detecting a nucleic acid in a sample.

IPC Classes  ?

  • C12Q 1/6853 - Nucleic acid amplification reactions using modified primers or templates
  • C12Q 1/6809 - Methods for determination or identification of nucleic acids involving differential detection

7.

A SOLID CONTACT AND AN ION-SELECTIVE ELECTRODE

      
Application Number SG2023050588
Publication Number 2024/049350
Status In Force
Filing Date 2023-08-29
Publication Date 2024-03-07
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Goh, Simin Shermin
  • Goh, Wei Peng
  • Seah, Kim Kui Georgina Estelle
  • Neo, Zhi Hao
  • Ng, Shi Hoe

Abstract

There are provided a method of treating a solid contact and a solid contact obtained from the method. There are also provided a method of preparing an ion-selective electrode and an ion-selective electrode prepared by the method. There is further provided a method of sensing an ion in a sample.

IPC Classes  ?

  • G01N 27/333 - Ion-selective electrodes or membranes
  • H01B 1/12 - Conductors or conductive bodies characterised by the conductive materials; Selection of materials as conductors mainly consisting of other non-metallic substances organic substances
  • H01G 11/48 - Conductive polymers
  • C08G 61/12 - Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule

8.

A PRESSURE SENSING DEVICE AND RELATED METHODS

      
Application Number 17766522
Status Pending
Filing Date 2020-10-09
First Publication Date 2024-02-29
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Kiryukhin, Maxim
  • Lim, Su Hui
  • Lau, Hooi Hong
  • Upton, Zee
  • Fernandez, Melissa Laura

Abstract

There is provided a pressure sensing device and related methods, the pressure sensing device comprising, a plurality of chambers for storing one or more visual indicators, wherein the plurality of chambers are configured to release the one or more visual indicators when a pressure exerted on the plurality of chambers exceeds one or more pressure thresholds. The plurality of chambers can be microchambers. The device may be used in conjunction with a bandaging system to indicate the pressure applied onto a site of treatment.

IPC Classes  ?

  • A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
  • A61F 13/08 - Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for contracting aneurisms

9.

ANTIMICROBIAL COMPOUNDS, METHODS OF PRODUCTION AND USES THEREOF

      
Application Number SG2023050447
Publication Number 2024/043829
Status In Force
Filing Date 2023-06-26
Publication Date 2024-02-29
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wong, Fong Tian
  • Ching, Kuan Chieh
  • Ng, Siew Bee
  • Lim, Yee Hwee
  • Kanaga Sundaram, Yoganathan S/o

Abstract

The present disclosure concerns a method of biosynthesizing an antimicrobial compound of Formula (I), the method comprising culturing a microbial cell that is engineered to overexpress fatty-acyl CoA synthase (FAS) or RedD; and isolating the antimicrobial compound of Formula (I) that is produced by the microbial cell; wherein the biosynthesis of antimicrobial compound of Formula (I) is upregulated by at least about 2-fold compared to a tetramic acid analogue derived from a wild type microbial cell. The present disclosure also concerns a compound of Formula (I) and their use in treating a microbial disease or condition.

IPC Classes  ?

  • A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61P 31/04 - Antibacterial agents
  • C12N 15/76 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces

10.

LEACHING DEVICE

      
Application Number SG2023050566
Publication Number 2024/043832
Status In Force
Filing Date 2023-08-16
Publication Date 2024-02-29
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NANYANG TECHNOLOGICAL UNIVERSITY (Singapore)
Inventor
  • Wong, Ten It
  • Zhou, Xiaodong
  • Ge, Liya
  • Lisak, Grzegorz
  • Zhao, Ke

Abstract

A leaching device (10) is provided. The leaching device (10) includes a motor (12) and a receptacle (14) rotatably coupled to the motor (12), the receptacle (14) being configured to receive a sample container. A plurality of ultrasonic transducers (16) is 5 attached to the receptacle (14). An ultrasonic generator (18) is coupled to the ultrasonic transducers (16). When in use, the ultrasonic generator (18) is configured to energise the ultrasonic transducers (16) to radiate ultrasonic waves to sonicate a sample in the sample container received in the receptacle (14). A controller (20) is configured to control operation of the motor (12) and the ultrasonic generator (18), the motor (12) and the 0 ultrasonic generator (18) being simultaneously operable.

IPC Classes  ?

  • B01F 29/00 - Mixers with rotating receptacles
  • B01F 31/80 - Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
  • G01N 33/24 - Earth materials
  • G01N 1/28 - Preparing specimens for investigation

11.

GENERATING AN OUTPUT FOR A RECTIFIED LINEAR UNIT (RELU)-ACTIVATED NEURON OF A NEURAL NETWORK

      
Application Number 18260585
Status Pending
Filing Date 2021-01-08
First Publication Date 2024-02-22
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Tan, Hong Meng Benjamin
  • Meftah, Souhail
  • Aung, Khin Mi Mi

Abstract

In some aspects, a set of input elements is obtained, at a rectified linear unit-activated neuron of a neural network based, on input data at the neuron. A first group and a second group of input elements are generated based on the set of input elements. The first group and the second group of input elements are associated with first weight elements and second weight elements, respectively. A first value is generated based on the first group of input elements and the first weight elements. A second value is generated based on the second group of input elements and the second weight elements. A third value and a fourth value are respectively generated based on a first operation and a second operation on the first value and the second value. An output of the neuron is generated based on the third value and the fourth value.

IPC Classes  ?

  • G06N 3/063 - Physical realisation, i.e. hardware implementation of neural networks, neurons or parts of neurons using electronic means

12.

ANTI-YELLOW FEVER VIRUS ANTIBODIES

      
Application Number SG2023050568
Publication Number 2024/039298
Status In Force
Filing Date 2023-08-17
Publication Date 2024-02-22
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wang, Cheng-I
  • Lim, Pei Yin

Abstract

There is provided an antigen binding protein that specifically binds to yellow fever virus wherein the antigen binding protein comprises (1) CDRL1-CDRL3 respectively comprising sequences of SEQ ID NOs: 1-3 and CDRH1-CDRH3 respectively having sequences of SEQ ID NOs: 7-9; or (2) CDRL1-CDRL3 respectively comprising sequences of SEQ ID NOs: 4-6 and CDRH1-CDRH3 respectively having sequences of SEQ ID NOs: 10-12. Also disclosed are polynucleotides, vectors, and host cells expressing the antigen binding protein thereof. Also disclosed are methods of detecting, kits, and methods of preventing or treating a yellow fever virus infection in a subject in need thereof.

IPC Classes  ?

  • C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • A61P 31/14 - Antivirals for RNA viruses

13.

METHOD AND SYSTEM FOR PRIVACY-PRESERVING LOGISTIC REGRESSION TRAINING BASED ON HOMOMORPHICALLY ENCRYPTED CIPHERTEXTS

      
Application Number 18260776
Status Pending
Filing Date 2021-01-08
First Publication Date 2024-02-22
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Jin, Chao
  • Chan, Fook Mun
  • Aung, Khin Mi Mi

Abstract

There is provided a method of privacy-preserving logistic regression training based on homomorphically encrypted ciphertexts. The method includes: obtaining a first packed ciphertext comprising at least a portion of a first training data sample packed into a first vector of slots thereof for training a privacy-preserving logistic regression model; obtaining a second packed ciphertext comprising a plurality of weights of the privacy-preserving logistic regression model packed into a first vector of slots thereof; determining at least a first output probability of the privacy-preserving logistic regression model based on the first packed ciphertext and the second packed ciphertext; and updating the plurality of weights based on the first output probability. There is also provided a corresponding system for privacy-preserving logistic regression training based on homomorphically encrypted data.

IPC Classes  ?

  • G06F 21/62 - Protecting access to data via a platform, e.g. using keys or access control rules
  • H04L 9/00 - Arrangements for secret or secure communications; Network security protocols

14.

A COMPOSITE AND A METHOD OF PREPARING THE SAME

      
Application Number 17425969
Status Pending
Filing Date 2020-01-21
First Publication Date 2024-02-15
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Zhang, Yugen
  • Wang, Jinquan

Abstract

There is provided a composite comprising an inorganic metal or alloy core at least partially covered by a protection layer comprising a carboxylate salt, a metal oxide, a metal oxide salt or a metal-amino acid complex. There is also provided a method of preparing the composite comprising an inorganic metal or alloy core at least partially covered by a protection layer comprising a carboxylate salt, a metal oxide, a metal oxide salt or a metal-amino acid complex, comprising the step of mixing a metal or alloy with an acid, at elevated temperature for a time duration, optionally in the presence of a solvent. There is also provided use of a composite as an antimicrobial agent, and uses of a composite in the treatment or prophylaxis of microbial infection. There is also provided a method of inhibiting microbial activity or treating a microbial infection or disease comprising administering an antimicrobial composition comprising said composite as disclosed herein to a subject or applying the antimicrobial composition on a surface.

IPC Classes  ?

  • A01N 59/16 - Heavy metals; Compounds thereof
  • C09D 5/14 - Paints containing biocides, e.g. fungicides, insecticides or pesticides
  • C09D 7/62 - Additives non-macromolecular inorganic modified by treatment with other compounds
  • A01N 25/12 - Powders or granules
  • A61K 33/06 - Aluminium, calcium or magnesium; Compounds thereof
  • A61K 33/32 - Manganese; Compounds thereof
  • A61K 33/30 - Zinc; Compounds thereof
  • A61K 33/26 - Iron; Compounds thereof
  • A61K 9/50 - Microcapsules
  • A01P 1/00 - Disinfectants; Antimicrobial compounds or mixtures thereof

15.

CD30 ANTIGEN-BINDING MOLECULES

      
Application Number SG2023050544
Publication Number 2024/035341
Status In Force
Filing Date 2023-08-07
Publication Date 2024-02-15
Owner
  • TESSA THERAPEUTICS LTD. (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Low, Lionel, Jianrong
  • Tan, Kar Wai
  • Ng, Chee Hoe
  • Kua, Lindsay

Abstract

The present disclosure provides antigen-binding molecules that bind to CD30, having novel biophysical and/or functional properties as compared to antigen-binding molecules disclosed in the prior art. Also provided is a chimeric antigen receptor (CAR) comprising the novel CD30-specific antigen-binding molecules. Also provided is a nucleic acid or plurality of nucleic acids encoding said antigen-binding molecule or CAR, an expression vector or a plurality of expression vectors comprising said nucleic acids, methods of making such molecules, and the use of such molecules in a method of medical treatment or prophylaxis.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • A61P 35/00 - Antineoplastic agents
  • A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection

16.

IL2RBETA/COMMON GAMMA CHAIN ANTIBODIES

      
Application Number 18344711
Status Pending
Filing Date 2023-06-29
First Publication Date 2024-02-15
Owner
  • Agency for Science, Technology and Research (Singapore)
  • Euchloe Bio Pte. Ltd. (Singapore)
Inventor
  • Brauer, Peter
  • Connolly, John Edward
  • Hopkins, Richard
  • Lai, Junyun
  • Low, Jianrong Lionel
  • Tan, Kar Wai
  • Wang, Cheng-I
  • Yeo, Siok Ping

Abstract

Antigen binding molecules capable of binding to CDI22 and/or common y′ chain (CDI32) are disclosed herein. Also disclosed are compositions comprising such antigen binding molecules, and uses and methods using the same.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61P 35/00 - Antineoplastic agents
  • C07K 16/46 - Hybrid immunoglobulins

17.

METHOD

      
Application Number 18449190
Status Pending
Filing Date 2023-08-14
First Publication Date 2024-02-15
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Bard, Frederic
  • Nguyen, Anh Tuan
  • Manon, Ros

Abstract

We describe a Cnx/ERp57 inhibitor for use in the treatment or prevention of cancer.

IPC Classes  ?

  • C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans

18.

METHODS OF PRODUCING JASMONATES

      
Application Number SG2023050446
Publication Number 2024/035336
Status In Force
Filing Date 2023-06-23
Publication Date 2024-02-15
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Pagac, Martin Patrick
  • Irudayaswamy, Antony Sagayaraj
  • Dawson, Thomas Larry, Jr

Abstract

MalasseziaMalassezia species.

IPC Classes  ?

  • C12P 7/24 - Preparation of oxygen-containing organic compounds containing a carbonyl group
  • C12N 1/16 - Yeasts; Culture media therefor
  • C12N 15/00 - Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12R 1/645 - Fungi

19.

AN IMPROVED GALACTOSE OXIDASE ENZYME PANEL FOR OXIDATION OF SECONDARY ALCOHOLS

      
Application Number SG2023050534
Publication Number 2024/035339
Status In Force
Filing Date 2023-08-01
Publication Date 2024-02-15
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Lim, Yee Hwee
  • Tay, Wei Peng Dillon
  • Miyajima, Jhoann Margarette Tristeza
  • Maurer-Stroh, Sebastian
  • Yeo, Wan Lin
  • Ang, Ee Lui

Abstract

Disclosed are modified galactose oxidase variants with enhanced protein expression, solubility, thermal stability, and enzymatic activity, and reduced enantioselectivity compared to wild-type galactose oxidase or galactose oxidase variants known in the art, and methods of producing the same.

IPC Classes  ?

  • C12P 7/26 - Ketones
  • C12N 9/04 - Oxidoreductases (1.), e.g. luciferase acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
  • C12N 15/52 - Genes encoding for enzymes or proenzymes

20.

B7-H3 ANTIGEN-BINDING MOLECULES

      
Application Number SG2023050545
Publication Number 2024/035342
Status In Force
Filing Date 2023-08-07
Publication Date 2024-02-15
Owner
  • TESSA THERAPEUTICS LTD (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Low, Lionel Jianrong
  • Tan, Kar Wai
  • Yeo, Siok Ping
  • Koh, Xinyu
  • Kua, Lindsay, Hsien Pin

Abstract

The present disclosure provides an antigen-binding molecule comprising a single domain antibody sequence that binds to B7-H3. It also discloses a chimeric antigen receptor (CAR) construct comprising said antigen-binding molecule, encoding nucleic acid/expression vector and T cells expressing said CAR and the use of the CAR-expressing T cells in a method of medical treatment, prophylaxis, and treatment of cancer.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • G01N 33/563 - Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
  • A61P 35/00 - Antineoplastic agents

21.

CHIMERIC ANTIGEN RECEPTOR DOMAINS

      
Application Number SG2023050546
Publication Number 2024/035343
Status In Force
Filing Date 2023-08-07
Publication Date 2024-02-15
Owner
  • TESSA THERAPEUTICS LTD. (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Low, Lionel Jianrong
  • Tan, Kar Wai
  • Ng, Chee Hoe
  • Tan, Jin Wei

Abstract

The present application describes novel chimeric antigen receptor (CAR) constructs comprising novel spacer region sequences. Also provided are cells comprising the CAR, a nucleic acid or a plurality of nucleic acids encoding the CAR, an expression vector or a plurality of expression vectors comprising said nucleic acids, methods of making such molecules, and the use of such molecules in a method of medical treatment or prophylaxis.

IPC Classes  ?

  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • A61P 35/00 - Antineoplastic agents
  • A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection

22.

METHOD FOR GENERATING EXTENDED SEQUENCE READS

      
Application Number 18479717
Status Pending
Filing Date 2023-10-02
First Publication Date 2024-02-08
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Quake, Stephen R.
  • Burkholder, William F.
  • Hong, Lewis Z.

Abstract

The present invention provides an approach to increase the effective read length of commercially available sequencing platforms to several kilobases and be broadly applied to obtain long sequence reads from mixed template populations. A method for generating extended sequence reads of long DNA molecules in a sample, comprising the steps of assigning a specific barcode sequence to each template DNA molecule in a sample to obtain barcode-tagged molecules: amplifying the barcode-tagged molecules; fragmenting the amplified barcode-tagged molecules to obtain barcode-containing fragments; juxtaposing the barcode-containing fragments to random short segments of the original DNA template molecule during the process of generating a sequencing library to obtain demultiplexed reads; and assembling the demultiplexed reads to obtain extended sequence reads for each DNA template molecule, is disclosed.

IPC Classes  ?

  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/6869 - Methods for sequencing

23.

MICROBIOME MARKERS

      
Application Number SG2023050542
Publication Number 2024/030081
Status In Force
Filing Date 2023-08-04
Publication Date 2024-02-08
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Png, Eileen
  • Ravikrishnan, Aarthi
  • Chng, Kern Rei
  • Nagarajan, Niranjan

Abstract

This invention relates to microbiome markers for healthy aging. There is provided, inter alia, a method of predicting or determining healthy aging in an individual, the method comprising: (a) determining the presence or an amount of at least one microorganism in a sample representing the individual's gut microbiome, wherein the at least one microorganism is selected from Table 1A, wherein an enrichment of said microorganisms is indicative of healthy aging; and/or (b) determining the presence or an amount of at least one microorganism in a sample representing the individual's gut microbiome, wherein the at least one microorganism is selected from Table 1 B, wherein a depletion of said microorganisms is indicative of healthy aging.

IPC Classes  ?

  • C12Q 1/689 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

24.

A PHOTOVOLTACHROMIC DEVICE

      
Application Number SG2023050516
Publication Number 2024/030076
Status In Force
Filing Date 2023-07-24
Publication Date 2024-02-08
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Jiang, Changyun
  • Goh, Wei Peng
  • Ang, Yong Long, Thomas
  • Tong, Shi Wun
  • Neo, Chi Jin Darren
  • Huang, Xiaohu

Abstract

A photovoltachromic device is provided. The photovoltachromic device may include a photovoltaic cell, and a transparent-reflective switchable device in light communication with the photovoltaic cell. The transparent-reflective switchable device may be operable between a reflective mode in which light falling thereon is reflected to the photovoltaic cell, and a transmission mode in which light falling thereon is directed through the transparent-reflective switchable device.

IPC Classes  ?

  • H02S 40/22 - Light-reflecting or light-concentrating means
  • H02S 20/20 - Supporting structures directly fixed to an immovable object
  • G02F 1/157 - Structural association of cells with optical devices, e.g. reflectors or illuminating devices
  • A01G 9/24 - Devices for heating, ventilating, regulating temperature, or watering, in greenhouses, forcing-frames, or the like
  • A01G 9/22 - Shades or blinds for greenhouses, or the like

25.

POLYMER PARTICLE PRODUCTION METHOD

      
Application Number 18359626
Status Pending
Filing Date 2023-07-26
First Publication Date 2024-02-01
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Mothe, Srinivasa Reddy
  • Thoniyot, Praveen

Abstract

A polymer particle production method includes: providing (12) one or more vinyl monomers; performing (14) free radical ring-opening polymerization (rROP) of cyclic ketene acetal (CKA) with the one or more vinyl monomers in a first organic solvent with a radical source to obtain a rROP reaction mixture; and emulsifying (16) the rROP reaction mixture in a second organic solvent to produce a plurality of polymer particles.

IPC Classes  ?

26.

TITANIUM-TANTALUM ALLOY AND METHOD OF FORMING THEREOF

      
Application Number 18483519
Status Pending
Filing Date 2023-10-09
First Publication Date 2024-02-01
Owner
  • Nanyang Technological University (Singapore)
  • Agency for Science, Technology and Research (Singapore)
Inventor
  • Sing, Swee Leong
  • Yeong, Wai Yee
  • Wiria, Florencia Edith

Abstract

A titanium-tantalum alloy having a titanium wt % ranging from 10% to 70% and wherein the titanium has a body centered cubic structure. A method of forming a titanium-tantalum alloy, the method comprising the steps of: (a) slicing a 3D CAD model of a part to be formed into a plurality of 2D image layers; (b) preparing a homogenous powder mixture of titanium powder and tantalum powder; (c) dispensing a layer of the powder mixture onto a processing bed; (d) performing powder bed fusion of the layer of the powder mixture according to one of the 2D image layers in one of: a vacuum environment and an inert gas environment; and performing steps (c) and (d) for each of the plurality of 2D image layers in succession.

IPC Classes  ?

  • C22C 14/00 - Alloys based on titanium
  • B33Y 10/00 - Processes of additive manufacturing
  • C22C 1/04 - Making non-ferrous alloys by powder metallurgy
  • B33Y 70/00 - Materials specially adapted for additive manufacturing
  • B22F 1/05 - Metallic powder characterised by the size or surface area of the particles
  • B22F 10/28 - Powder bed fusion, e.g. selective laser melting [SLM] or electron beam melting [EBM]

27.

METHOD OF MODULATING PRODUCTION OF SECONDARY METABOLITES

      
Application Number SG2023050496
Publication Number 2024/025462
Status In Force
Filing Date 2023-07-14
Publication Date 2024-02-01
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Tay, Wei Peng, Dillon
  • Lim, Yee Hwee
  • Wong, Fong Tian
  • Ng, Siew Bee
  • Kanagasundaram, Yoganathan

Abstract

actinomycetesactinomycetesactinomycetes bacterium. In one embodiment, the metabolite is valinomycin, daidzein, fluvirucin, demethyllydicamycin, or TPU-0037 analogues A, C and D.

IPC Classes  ?

  • C12N 15/76 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces
  • C12R 1/465 - Streptomyces

28.

DEVICE FOR PROCESSING HOMOMORPHICALLY ENCRYPTED DATA

      
Application Number 18254132
Status Pending
Filing Date 2021-11-24
First Publication Date 2024-02-01
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Yang, Hong
  • Kang, Dee Meng
  • Al Badawi, Ahmad Qaisar Ahmad
  • Aung, Khin Mi Mi

Abstract

There is provided a device for processing homomorphically encrypted data. The device includes: inter-line butterfly array blocks, each inter-line butterfly array block including inter-line modulus butterfly units, each inter-line modulus butterfly unit being configured to perform a modulus butterfly operation based on a computation pair of data points received corresponding to a pair of input data points at a same row of a matrix of input data points; intra-line butterfly array blocks, each intra-line butterfly array block including intra-line modulus butterfly units, each intra-line modulus butterfly unit being configured to perform a modulus butterfly operation based on a computation pair of data points received corresponding to a pair of input data points at a same column of the matrix of input data points; and a clock counter communicatively coupled to each inter-line butterfly array block and each intra-line butterfly array block, and configured to output a counter signal for controlling each inter-line butterfly array block and each intra-line butterfly array block to operate with single cycle initiation interval. The matrix of input data points includes columns of input data points, whereby parallel input data points derived from the homomorphically encrypted data are arranged into the columns of input data points. Furthermore, the inter-line butterfly array blocks and the intra-line butterfly array blocks are arranged in series to form a pipeline for processing the matrix of input data points.

IPC Classes  ?

  • H04L 9/00 - Arrangements for secret or secure communications; Network security protocols
  • G06F 9/38 - Concurrent instruction execution, e.g. pipeline, look ahead
  • G06F 7/72 - Methods or arrangements for performing computations using a digital non-denominational number representation, i.e. number representation without radix; Computing devices using combinations of denominational and non-denominational quantity representations using residue arithmetic

29.

PIEZOELECTRIC DEVICE AND METHOD OF FORMING THE SAME

      
Application Number 18044493
Status Pending
Filing Date 2021-09-23
First Publication Date 2024-01-25
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Ng, Eldwin Jiaqiang
  • Wang, Nan
  • Merugu, Srinivas
  • Sharma, Jaibir

Abstract

Various embodiments may relate to a piezoelectric device. The piezoelectric device may include a substrate, and a layered stacked arrangement anchored to the substrate. The layered stacked arrangement may include a piezoelectric layer. The stacked arrangement may also include a first electrode on a first side of the piezoelectric layer. The stacked arrangement may further include a second electrode on a second side of the piezoelectric layer opposite the first side. The piezoelectric layer may include a first region including one or more dipole domains of a first type, and one or more dipole domains of a second type. The first electrode may be at least partially in contact with the first region and at least partially in contact with the second region.

IPC Classes  ?

  • H10N 30/20 - Piezoelectric or electrostrictive devices with electrical input and mechanical output, e.g. functioning as actuators or vibrators
  • H10N 30/853 - Ceramic compositions
  • H10N 30/076 - Forming of piezoelectric or electrostrictive parts or bodies on an electrical element or another base by depositing piezoelectric or electrostrictive layers, e.g. aerosol or screen printing by vapour phase deposition

30.

LIGHT MODULATING DEVICE

      
Application Number SG2023050475
Publication Number 2024/019658
Status In Force
Filing Date 2023-07-06
Publication Date 2024-01-25
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Jiang, Changyun
  • Goh, Wei Peng

Abstract

Various embodiments refer to a light modulating device. The device may include a first support comprising a first photovoltaic cell on a surface and a first light-reflector on an opposing surface, and a second support comprising a second photovoltaic cell on a surface and second light-reflector on an opposing surface. The first support and the second support may be pivotably coupled to each other along an edge portion of the respective support, and movable between a collapsed position in which the surfaces comprising the first photovoltaic cell and the second photovoltaic cell are opposed and inwardly facing and an extended position in which the surfaces comprising the first photovoltaic cell and the second photovoltaic cell lie substantially in the same plane, to modulate transmission of light.

IPC Classes  ?

  • H02S 20/30 - Supporting structures being movable or adjustable, e.g. for angle adjustment
  • H02S 30/20 - Collapsible or foldable PV modules
  • F24S 30/48 - Arrangements for moving or orienting solar heat collector modules for rotary movement with three or more rotation axes or with multiple degrees of freedom
  • A01G 9/24 - Devices for heating, ventilating, regulating temperature, or watering, in greenhouses, forcing-frames, or the like
  • A01G 9/22 - Shades or blinds for greenhouses, or the like

31.

METHOD OF CONVERTING POLYPROPYLENE TO OXIDIZED POLYPROPYLENE MICRO-SIZED PARTICLES HAVING HIERARCHICAL NANOSTRUCTURES AND MATERIAL COMPRISING SAID PARTICLES

      
Application Number SG2023050505
Publication Number 2024/019664
Status In Force
Filing Date 2023-07-18
Publication Date 2024-01-25
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Zhang, Yugen
  • Li, Xiukai

Abstract

There is provided a method of converting polypropylene (PP) to oxidized polypropylene (OPP) micro-sized particles having hierarchical nanostructures, the method comprising: oxidizing a PP containing source in the presence of a catalyst to obtain OPP; dissolving the OPP in a first liquid to obtain a dissolved solution of OPP; and precipitating OPP micro-sized particles having hierarchical nanostructures from the dissolved solution of OPP by adding the dissolved solution of OPP to a second liquid. Also provided is a material comprising oxidized polypropylene (OPP) micro-sized particles having hierarchical nanostructures.

IPC Classes  ?

  • C08F 10/06 - Propene
  • C08J 11/08 - Recovery or working-up of waste materials of polymers without chemical reactions using selective solvents for polymer components
  • C08J 3/14 - Powdering or granulating by precipitation from solutions
  • B82Y 30/00 - Nanotechnology for materials or surface science, e.g. nanocomposites
  • B82Y 40/00 - Manufacture or treatment of nanostructures

32.

METHOD OF INHIBITING EPITHELIAL-MESENCHYMAL TRANSITION AND CANCER METASTASIS

      
Application Number SG2023050510
Publication Number 2024/019667
Status In Force
Filing Date 2023-07-21
Publication Date 2024-01-25
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Tam, Wai Leong
  • Pathak, Elina

Abstract

The invention relates generally to field of cancer biology. Provided herein are methods of inhibiting epithelial- mesenchymal transition (EMT) and for inhibiting or preventing metastasis in a cancer cell, the methods comprising contacting the cancer cell with an effective amount of a histone deacetylase 6 (HDAC6) inhibitor and a glycogen synthase kinase-3[3 (GSK30) inhibitor. Methods of screening for an inhibitor of EMT comprising a reporter cell line, which comprises a ZEB1 inducible construct, and an epithelial gene reporter construct are also provided herein.

IPC Classes  ?

  • A61K 31/195 - Carboxylic acids, e.g. valproic acid having an amino group
  • A61K 31/395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61P 35/00 - Antineoplastic agents

33.

SOUND ABSORPTION MATERIAL AND METHOD OF FABRICATING SAME

      
Application Number SG2023050481
Publication Number 2024/019660
Status In Force
Filing Date 2023-07-10
Publication Date 2024-01-25
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Yao, Kui
  • Mohamed Yousry, Yasmin
  • Chen, Shu Ting
  • Lim, Poh Chong

Abstract

A sound absorption material and a method (10) of fabricating a sound absorption material are provided. The method (10) includes preparing (12) a first precursor solution or suspension of one of a first triboelectric material and a second triboelectric material; and forming (16) a porous structure by using the first precursor solution or suspension in one of a templating technique with a second precursor solution or suspension of the other one of the first and second triboelectric material, an immersion technique with the other one of the first and second triboelectric materials, and an electrospinning technique with the other one of the first and second triboelectric materials. The porous structure includes a hybrid composite of the first triboelectric material having a first charge affinity and the second triboelectric material having a second charge affinity, wherein the first charge affinity is greater than the second charge affinity.

IPC Classes  ?

34.

ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

      
Application Number 18453418
Status Pending
Filing Date 2023-08-22
First Publication Date 2024-01-18
Owner
  • Chugai Seiyaku Kabushiki Kaisha (Japan)
  • Agency for Science, Technology and Research (Singapore)
Inventor
  • Sampei, Zenjiro
  • Koo, Xing'Er Christine
  • Fink, Katja
  • Zuest, Roland

Abstract

The disclosure provides anti-DENV antibodies and methods of making and using the same. Nucleic acids encoding the anti-DENV antibodies and host cells comprising the nucleic acids are also provided. The anti-DENV antibodies have uses that include treating DENV infection. The disclosure also provided polypeptides containing a variant Fc region and methods of making and using the same. Nucleic acids encoding the polypeptides and host cells comprising the nucleic acids are also provided. The polypeptides have uses that include treating a viral infection. Also claimed is a polypeptide comprising a Fc variant comprising at least one amino acid alteration in a parent Fc region, wherein the variant Fc region has a substantially decreased FcYR-binding activity and does not have a substantially decreased C1 q-binding activity when compared to the parent Fc region.

IPC Classes  ?

  • C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses

35.

OPTICAL SYSTEM AND METHOD OF FORMING THE SAME, METHOD OF FORMING A MULTI-COLOR IMAGE

      
Application Number SG2022050485
Publication Number 2024/015012
Status In Force
Filing Date 2022-07-12
Publication Date 2024-01-18
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Baranikov, Anton
  • Khaidarov, Egor
  • Lassalle, Emmanuel
  • Paniagua Dominguez, Ramon Jose
  • Kuznetsov, Arseniy

Abstract

Various embodiments may relate to an optical system. The optical system may include a plurality of color filters, a first color filter of the plurality of color filters configured to select light of different wavelength ranges representing different color channels. The optical system may also include a plurality of metalenses, each of the plurality of metalenses associated with a respective color channel of the plurality of color channels. Each of the plurality of metalenses may have a focal length, the plurality of metalenses having equal focal lengths such that the different color channels are combined on a common focal plane to form a multi-color image. Each of the plurality of metalenses may include a plurality of nanostructures, have a (FOV) field of view of more than 30 degrees, and a desired working spectral bandwidth dependent on an extended depth of focus, a central wavelength of the associated color channel, and the focal length at the central wavelength.

IPC Classes  ?

  • G02B 1/00 - Optical elements characterised by the material of which they are made; Optical coatings for optical elements
  • H04N 23/10 - Cameras or camera modules comprising electronic image sensors; Control thereof for generating image signals from different wavelengths
  • B82Y 20/00 - Nanooptics, e.g. quantum optics or photonic crystals
  • H04N 23/55 - Optical parts specially adapted for electronic image sensors; Mounting thereof

36.

ANTIGEN BINDING MOLECULES AND USES THEREOF

      
Application Number 18034289
Status Pending
Filing Date 2021-10-26
First Publication Date 2024-01-18
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Fong, Wey Jia
  • Choo, Boon Hwa
  • Ding, Mei Yee Vanessa
  • Chin, Chui Ping

Abstract

The invention relates generally to antigen-binding molecules that specifically bind to Myosin Heavy Chain 9 (MYH9) and uses thereof for the treatment of specific cancers, such as mast cell tumors. In one embodiment, the MYH9 is canine MYH9 and the antigen-binding molecule is an antibody. In another embodiment, the antigen-binding molecule is conjugated to a toxin, for the treatment of canine mast cell tumors.

IPC Classes  ?

  • C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
  • A61P 35/00 - Antineoplastic agents

37.

A DEVICE AND METHOD FOR VASCULARISING A CELL AGGREGATE

      
Application Number 18255146
Status Pending
Filing Date 2021-12-01
First Publication Date 2024-01-18
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Adriani, Giulia
  • Pavesi, Andrea

Abstract

There is provided a device for vascularising a cell aggregate, the device comprising: a matrix region configured to contain a gel-like matrix and cells that form a vasculature network within th ematrix region. The matrix region having at least one opening for positioning the cell aggregate therein based on a desired three-dimensional spatial location; and one or more fluidic regions configured to contain a supporting fluid that is capable of supporting vascularisation of the cell aggregate, the one or more fluidic regions being in fluid communication with the matrix region, wherein a flow passage from the one or more fluidic regions to a gel-like matrix disposed in the matrix region is configured to allow three-dimensional vascularisation around the cell aggregate and perfusion of the vasculature once formed. There is also provided a chip comprising a plurality of the device as disclosed herein and a method for vascularising a cell aggregate.

IPC Classes  ?

  • C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues

38.

Acoustic Resonator and Method of Forming the Same

      
Application Number 18258347
Status Pending
Filing Date 2021-02-03
First Publication Date 2024-01-18
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Zhu, Yao
  • Liu, Chen
  • Wang, Nan

Abstract

Various embodiments may relate to an acoustic resonator. The acoustic resonator may include a piezoelectric layer. The acoustic resonator may also include a first electrode in contact with a first surface of the piezoelectric layer. The acoustic resonator may further include a plurality of dielectric structures in contact with the first surface of the piezoelectric layer. The acoustic resonator may additionally include a second electrode in contact with a second surface of the piezoelectric layer opposite the first surface. The first electrode may include a plurality of electrode structures. A dielectric structure of the plurality of dielectric structures may be in contact with a pair of neighboring electrode structures of the plurality of electrode structures.

IPC Classes  ?

  • H10N 30/067 - Forming single-layered electrodes of multilayered piezoelectric or electrostrictive parts
  • H10N 30/87 - Electrodes or interconnections, e.g. leads or terminals
  • H03H 9/17 - Constructional features of resonators consisting of piezoelectric or electrostrictive material having a single resonator
  • H10N 30/07 - Forming of piezoelectric or electrostrictive parts or bodies on an electrical element or another base
  • H03H 3/02 - Apparatus or processes specially adapted for the manufacture of impedance networks, resonating circuits, resonators for the manufacture of electromechanical resonators or networks for the manufacture of piezoelectric or electrostrictive resonators or networks

39.

NEURAL PROCESSING CORE FOR A NEURAL NETWORK AND METHOD OF OPERATING THEREOF

      
Application Number SG2023050498
Publication Number 2024/015023
Status In Force
Filing Date 2023-07-14
Publication Date 2024-01-18
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Jiang, Wenyu
  • Chee, Piew Yoong
  • Xiao, Rui

Abstract

A neural processing core for a neural network is provided, which includes: a synaptic memory array including synaptic memory cells arranged in a plurality of memory cell rows and columns; a plurality of first input activation lines connected to the plurality of memory cell rows, respectively, of the synaptic memory array and configured to receive a plurality of first input activation signals, respectively, to the plurality of memory cell rows; and a plurality of first sensing lines connected to the plurality of memory cell columns, respectively, of the synaptic memory array and configured to output a plurality of first analog electrical signals, respectively, from the plurality of memory cell columns. In particular, the neural processing core is configured to control the synaptic memory cells of the synaptic memory array in a column-wise manner. There is also provided a corresponding method of operating the neural processing core for a neural network.

IPC Classes  ?

  • G06N 3/065 - Analogue means
  • G11C 11/54 - Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using elements simulating biological cells, e.g. neuron

40.

Expression System for Protein Production and Screening

      
Application Number 18025437
Status Pending
Filing Date 2021-10-01
First Publication Date 2024-01-11
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Yang, Yuan Sheng
  • Yeo, Hwee Ming Jessna
  • Mariati, Mariati
  • Goh Fang, Shiyi

Abstract

Disclosed is an expression system for an antigen binding molecule and the uses thereof.

IPC Classes  ?

  • C07K 16/46 - Hybrid immunoglobulins
  • G01N 33/68 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • C07K 14/71 - Receptors; Cell surface antigens; Cell surface determinants for growth regulators
  • C07K 14/705 - Receptors; Cell surface antigens; Cell surface determinants

41.

CNX ANTIGEN-BINDING MOLECULES

      
Application Number EP2023068932
Publication Number 2024/008960
Status In Force
Filing Date 2023-07-07
Publication Date 2024-01-11
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • ALBATROZ THERAPEUTICS PTE. LTD. (Singapore)
  • RICHARD IAN CLEGG (United Kingdom)
Inventor
  • Bard, Frederic
  • Wang, Cheng-I
  • Chia, Zhi Hui Joanne
  • Ngoh, Eve
  • Le Guezennec, Xavier
  • Min, Tham Keit
  • Nguyen, Anh Tuan
  • Bennion, Rebecca

Abstract

Antigen binding molecules capable of binding to calnexin (CNX) are disclosed herein. Also disclosed are chimeric antigen receptors, antibody-drug conjugates, and compositions comprising such antigen binding molecules, as well as nucleic acids, vectors and cells. Uses and methods involving antigen binding molecules capable of binding to calnexin (CNX) are also disclosed.

IPC Classes  ?

  • C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
  • A61P 35/00 - Antineoplastic agents
  • A61P 35/04 - Antineoplastic agents specific for metastasis
  • A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

42.

OPTICAL SYSTEM, METHOD OF FORMING THE SAME, METHOD OF DIRECT LASER WRITING

      
Application Number SG2022050478
Publication Number 2024/010520
Status In Force
Filing Date 2022-07-08
Publication Date 2024-01-11
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wang, Zeng
  • Teng, Jinghua

Abstract

Various embodiments may relate to an optical system. The optical system may include a laser source for emitting one or more laser beams. The optical system may also include a metalens, a first stage mounting the metalens, a first motor configured to move the first stage, a second stage for holding a sample, and a second motor configured to move the second stage. The optical system may include an objective, a third stage configured to hold the objective, and a third motor configured to move the third stage. The optical system may also include a detector and a screen including or defining a pinhole, the screen arranged between the objective and the detector. The optical system may also include a processor in electrical communication with the first motor, the second motor and the third motor.

IPC Classes  ?

  • G03F 7/20 - Exposure; Apparatus therefor
  • B82Y 40/00 - Manufacture or treatment of nanostructures
  • G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor

43.

OLIGONUCLEOTIDES

      
Application Number SG2023050470
Publication Number 2024/010524
Status In Force
Filing Date 2023-07-05
Publication Date 2024-01-11
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NATIONAL UNIVERSITY OF SINGAPORE (Singapore)
  • KYAN THERAPEUTICS (Singapore)
Inventor
  • Thng, Kai Hao, Dexter
  • Chow, Kai-Hua, Edward
  • Wee, Keng Boon, Dave
  • Binte Mohamed Abdul Rashid, Masturah
  • Pigini, Paolo

Abstract

BRD4BRD4CHEK1CHEK1CHEK1 gene. The invention also relates to the use of SSOs as therapeutic candidates for treating Myc-driven cancers.

IPC Classes  ?

  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61P 35/00 - Antineoplastic agents

44.

METHOD OF IDENTIFYING ONE OR MORE BACTERIA

      
Application Number SG2023050472
Publication Number 2024/010526
Status In Force
Filing Date 2023-07-05
Publication Date 2024-01-11
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD (Singapore)
Inventor
  • Olivo, Malini
  • Choolani, Mahesh Arjandas
  • Wang, Yusong
  • Perumal, Jayakumar
  • Dev, Kapil
  • Balasundaram, Ghayathri
  • Moothanchery, Mohesh
  • Unnimadhava Kurup Soudamini Amma, Dinish

Abstract

A method of identifying one or more bacteria from a sample, wherein the one or more bacteria is suspected to be present in the sample, is provided. The method may include providing an aqueous suspension comprising a bacteria-SERS nanoparticle complex, wherein the bacteria-SERS nanoparticle complex comprises (i) a SERS nanoparticle and (ii) the one or more bacteria suspected to be present in the sample; depositing the aqueous suspension comprising the bacteria-SERS nanoparticle complex on a substrate having structures coated with a SERS-active material to dispose the bacteria-SERS nanoparticle complex on the substrate; irradiating the bacteria-SERS nanoparticle complex disposed on the substrate with laser to generate one or more SERS signals; having a SERS-spectroscopic module operable to render one or more SERS spectral data corresponding to the one or more SERS signals; and having a process module operable to identify the presence or absence of the one or more bacteria from the one or more SERS spectral data.

IPC Classes  ?

  • C12Q 1/04 - Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
  • G01N 21/65 - Raman scattering

45.

A SPATIAL LIGHT MODULATOR

      
Application Number 18039414
Status Pending
Filing Date 2020-12-10
First Publication Date 2024-01-04
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Zhu, Di
  • Chai, Kevin Tshun Chuan
  • Mani, Aarthy
  • Do, Anh Tuan

Abstract

This document describes a spatial light modulator that comprises a pixel array having a plurality of pixels whereby each pixel in this array is communicatively coupled to a digital pixel circuit which are in turn all coupled to a bit-plane control circuit. The bit-plane control circuit is configured to generate, using a Pulse Code Modulation (PCM) algorithm, bit-plane signals that are used to control the sample and hold functions performed by each of the digital pixel circuits so that the pixel array may carry out its scanning function accurately and in a power efficient manner.

IPC Classes  ?

  • G11C 11/418 - Address circuits
  • G02F 1/133 - Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
  • G02F 1/1343 - Electrodes
  • G02F 1/1368 - Active matrix addressed cells in which the switching element is a three-electrode device
  • G09G 3/36 - Control arrangements or circuits, of interest only in connection with visual indicators other than cathode-ray tubes for presentation of an assembly of a number of characters, e.g. a page, by composing the assembly by combination of individual elements arranged in a matrix by control of light from an independent source using liquid crystals

46.

OLIGONUCLEOTIDES

      
Application Number SG2023050458
Publication Number 2024/005715
Status In Force
Filing Date 2023-06-28
Publication Date 2024-01-04
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • THE JIKEI UNIVERSITY (Japan)
Inventor
  • Ow, Jin Rong
  • Imagawa, Eri
  • Tabaglio, Tommaso
  • Oishi, Kimihiko
  • Wee, Keng Boon, Dave

Abstract

The present invention relates to splice-switching oligonucleotides (SSOs) capable of altering the slicing of a pre-mRNA encoding a variant of the SLC25A13 gene, as well as the use of the same SSOs for treating citrin deficiency. In an embodiment, a SSO that binds to a site within a target region present on a pre-mRNA transcript of the SLC25A13 gene, wherein the binding of the SSO induces the exclusion of SLC25A13-PE5 from a mature mRNA transcript of the SLC25A13 gene. In another embodiment, the target region having at least 95% sequence identity to SEQ ID NO: 28.

IPC Classes  ?

  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61P 3/00 - Drugs for disorders of the metabolism

47.

ANALYSER AND COMPUTER-IMPLEMENTED METHOD FOR POLLUTANT DETECTION

      
Application Number SG2023050465
Publication Number 2024/005719
Status In Force
Filing Date 2023-06-30
Publication Date 2024-01-04
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NANYANG TECHNOLOGICAL UNIVERSITY (Singapore)
Inventor
  • Wong, Ten It
  • Zhou, Xiao Dong
  • Zhao, Ke
  • Ge, Liya
  • Lisak, Grzegorz

Abstract

An analyser (10, 100) for pollutant detection and a computer-implemented method (200) for pollutant detection are provided. The analyser (10, 100) includes one 5 or more electrochemical detection units (12, 102), one or more processors (14), a non-transitory computer-readable memory (16) and a display (18). Each of the one or more electrochemical detection units (12, 102) is configured to receive a control voltage signal according to a pollutant-specific detection protocol and output a measured current signal based on a measured electrical current from an electrode chip (20). The non-transitory 0 computer-readable memory (16) stores a detection protocol for each of a plurality of pollutants, a characterisation curve for each of the pollutants and computer program instructions executable by the one or more processors (14) to perform operations for pollutant detection, the operations comprising: identifying a current peak in the measured current signal; determining a peak intensity corresponding to the identified current peak; 5 and determining a concentration of a selected pollutant from the characterisation curve of the selected pollutant based on the determined peak intensity. The display (18) is configured to display the concentration of the selected pollutant.

IPC Classes  ?

48.

SYSTEM AND METHOD FOR CLASSIFICATION OF BASAL CELL CARCINOMA BASED ON CONFOCAL MICROSCOPY

      
Application Number SG2023050380
Publication Number 2023/249552
Status In Force
Filing Date 2023-05-29
Publication Date 2023-12-28
Owner
  • NATIONAL SKIN CENTRE (SINGAPORE) PTE LTD (Singapore)
  • NANYANG TECHNOLOGICAL UNIVERSITY (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Thng, Steven Tien Guan
  • Chuah, Sai Yee
  • Xie, Jun
  • Kong, Wai-Kin Adams
  • Lin, Li

Abstract

A system for classification of basal cell carcinoma (BCC) and a method of classifying basal cell carcinoma (BCC) may be provided, the system comprising a processing module configured to receive an input image sequence comprising a plurality of images; and a prediction module coupled to the processing module, the prediction module comprising a hierarchical ensemble structure of a plurality of classification models; wherein the processing module is configured to process each image as a whole image to obtain a plurality of first sub-sections and to further process each first sub-section to obtain a corresponding plurality of second sub-sections; further wherein the processing module is configured to transmit the each first sub-section to a first classification model of the prediction module trained to process the first sub-sections and to transmit each of the corresponding plurality of second sub- sections to a second classification model of the prediction module trained to process the second sub-sections, further wherein the prediction module is configured to determine a probability of BCC of the each image of the input image sequence based on a plurality of respective block prediction results corresponding to the first sub-sections of the each image; and further wherein the prediction module is configured to determine a BCC classification of the input image sequence based on the determined probability of BCC of each image of the input image sequence.

IPC Classes  ?

  • G06T 7/00 - Image analysis
  • G06N 20/20 - Ensemble learning
  • G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
  • G16B 40/00 - ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

49.

BIOACTIVE POLYETHYLENE COPOLYMER, POLYETHYLENE MACROMOLECULE AND RELATED METHODS THEREOF

      
Application Number 18251108
Status Pending
Filing Date 2020-10-30
First Publication Date 2023-12-28
Owner
  • Agency for Science, Technology and Research (Singapore)
  • Mitsui Chemicals, Inc. (Japan)
Inventor
  • Teo, Peili
  • Makio, Haruyuki
  • Guo, Jiayi
  • Park, Eun Ju
  • Teo, Yew Chin

Abstract

There is provided a bioactive polyethylene copolymer with a poly(norbornene) backbone comprising one or more repeating units represented by general formula (I) and one or more repeating units represented by general formula (II). Also provided are a polyethylene macromolecule, a material comprising said bioactive polyethylene copolymer, a method of preparing said bioactive polyethylene copolymer and a method of preparing said polyethylene macromolecule.

IPC Classes  ?

  • C08G 81/02 - Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
  • A61K 31/787 - Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom

50.

A GRIPPING DEVICE

      
Application Number 18251877
Status Pending
Filing Date 2021-11-03
First Publication Date 2023-12-21
Owner
  • National University of Singapore (Singapore)
  • Agency for Science, Technology and Research (Singapore)
Inventor
  • Khin, Phone May
  • Low, Jin Huat
  • Chen, Chao-Yu
  • Yeow, Chen Hua
  • Zhang, Ying

Abstract

A gripping device comprising: a base; at least one pair of extendable linkages connected at a proximal end to the base; each extendable linkage having a gripping finger extending from a distal end of the extendable linkage; wherein the extendable linkages are arranged to extend or retract from the base so as to increase a radial distance between the gripping fingers.

IPC Classes  ?

  • B25J 15/12 - Gripping heads having finger members with flexible finger members
  • B25J 15/10 - Gripping heads having finger members with three or more finger members
  • B25J 15/06 - Gripping heads with vacuum or magnetic holding means

51.

Bioactive Synthetic Copolymer, Bioactive Macromolecule and Related Methods Thereof

      
Application Number 18251144
Status Pending
Filing Date 2020-10-30
First Publication Date 2023-12-14
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Teo, Peili
  • Guo, Jiayi
  • Teo, Yew Chin
  • Park, Eun Ju

Abstract

There is provided a bioactive synthetic copolymer with a poly(norbornene) backbone comprising one or more repeating units represented by general formula (I) and one or more repeating units represented by general formula (II). Also provided are a bioactive macromolecule, a material comprising said bioactive synthetic copolymer, a method of preparing said bioactive synthetic copolymer and a method of preparing said bioactive macromolecule. There is provided a bioactive synthetic copolymer with a poly(norbornene) backbone comprising one or more repeating units represented by general formula (I) and one or more repeating units represented by general formula (II). Also provided are a bioactive macromolecule, a material comprising said bioactive synthetic copolymer, a method of preparing said bioactive synthetic copolymer and a method of preparing said bioactive macromolecule.

IPC Classes  ?

  • C08G 61/08 - Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aliphatic carbon atoms prepared by ring-opening of carbocyclic compounds of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring

52.

BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF

      
Application Number 18144641
Status Pending
Filing Date 2023-05-08
First Publication Date 2023-12-07
Owner Agency for Science, Technology and Research (Singapore)
Inventor Adsool, Vikrant Arun

Abstract

The present disclosure relates to derivatives of bicyclic compounds and their uses in therapy. In particular, the present disclosure relates to derivatives of bicyclic compounds for use in modulating kinase enzymatic activity and accordingly modulating kinase-dependent diseases and conditions such as cancer and in specific embodiments, hepatocellular carcinoma (HCC). The present disclosure also relates to methods of synthesizing these compounds.

IPC Classes  ?

  • C07D 491/08 - Bridged systems
  • C07D 215/233 - Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
  • C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 451/06 - Oxygen atoms
  • C07D 451/14 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

53.

MICROFLUIDIC ASSAYS AND USES THEREOF

      
Application Number SG2023050317
Publication Number 2023/234856
Status In Force
Filing Date 2023-05-08
Publication Date 2023-12-07
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NATIONAL UNIVERSITY OF SINGAPORE (Singapore)
Inventor
  • Tay, Zirui, Matthew
  • Lin, Weikang, Nicholas
  • Cheow, Lih Feng
  • Chen, Chia-Hung
  • Rénia, Laurent Claude Stéphane
  • Ng, Fong Poh, Lisa

Abstract

The present disclosure concerns a microfluidic method of assaying antibody secreting cells (ASCs), comprising the steps of isolating ASCs within droplets such that each droplet encapsulates only one ASC; iincubating the droplets of step a) to accumulate antibodies within the droplets; picoinjecting virus into the droplets of step b) to form immune complex droplets; picoinjecting host cells into the immune complex droplets to form neutralised droplets and infected droplets; and sorting the infected droplets from the neutralised droplets, based on infection of the host cells by the virus, to assay the ASCs within the neutralised droplets. The present disclosure also concerns a microfluidic platform thereof.

IPC Classes  ?

  • G01N 33/50 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers

54.

METHOD OF IDENTIFYING A SUBJECT FOR THERAPY

      
Application Number SG2023050216
Publication Number 2023/234853
Status In Force
Filing Date 2023-03-30
Publication Date 2023-12-07
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • SINGAPORE HEALTH SERVICES PTE LTD (Singapore)
Inventor
  • Shanmugam, Raghuvaran
  • Tergaonkar, Vinay Bhimrao Krishna
  • Tan, Iain Bee Huat
  • Macalinao, Dominique Camat
  • Chong, Qingqing Dawn

Abstract

The disclosure relates to methods of treatment and methods of identifying subjects for such treatment based on levels of pirin and/or iron in samples from the subject. In one embodiment, the subject is suffering from cancer, such as colorectal cancer, hemochromatosis or anaemia. In one embodiment, the treatment includes administration of iron chelator or pirin inhibitor.

IPC Classes  ?

  • G01N 33/574 - Immunoassay; Biospecific binding assay; Materials therefor for cancer
  • G01N 33/68 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • G01N 33/84 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
  • A61K 31/5375 - 1,4-Oxazines, e.g. morpholine
  • A61K 31/16 - Amides, e.g. hydroxamic acids
  • A61P 35/00 - Antineoplastic agents

55.

SENSOR-BASED TRAINING INTERVENTION

      
Application Number 18030717
Status Pending
Filing Date 2020-10-07
First Publication Date 2023-11-30
Owner
  • Agency for Science, Technology and Research (Singapore)
  • NATIONAL UNIVERSITY OF SINGAPORE (Singapore)
Inventor
  • Chin, Zheng Yang
  • Zhang, Haihong
  • Guan, Cuntai
  • Wang, Chuan Chu
  • Lee, Tih Shih

Abstract

Disclosed is a system for sensor-based training intervention. The system includes one or more electroencephalogram (EEG) sensors for retrieving brain signals of a subject, one or more sensors for retrieving eye tracking data of one or both eyes of the subject, and one or more processors. The one or more processors are configured to model a joint state space of the brain signals and eye tacking data by combining the brain signals and eye tracking data into combined data using sequential Bayesian fusion, and measure a visuospatial attention indicator from combined data.

IPC Classes  ?

56.

FUSION PROTEIN FOR BACTERIAL SURFACE DISPLAY

      
Application Number 18245249
Status Pending
Filing Date 2021-09-10
First Publication Date 2023-11-30
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Tay, Richie Pei Kun
  • Ow, Siak Wei

Abstract

The invention relates generally to the field of molecular biology and microbiology. Provided herein is an expression construct encoding a fusion protein. In one embodiment, there is provided an expression construct encoding a fusion protein, the expression construct comprising a nucleic acid encoding a first polypeptide for expression and a second polypeptide derived from the cell wall targeting region of a Lactobacillus plantarum Lys2 autolysin, wherein the first and second polypeptides are joined to form a fusion protein. In a specific embodiment, the second polypeptide comprises the CAD4a domain, which is a truncated domain containing only R1-R3 of the five-repeat SH3_5 domain of the Lys2 autolysin. Provided herein is also a fusion protein and the use of a fusion protein as defined herein.

IPC Classes  ?

  • C07K 14/335 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase

57.

METHOD FOR FORMING A TITANIA-COATED INORGANIC PARTICLE

      
Application Number 18230131
Status Pending
Filing Date 2023-08-03
First Publication Date 2023-11-30
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Chen, Chao
  • Li, Xu
  • Wang, Suxi
  • Zhang, Xikui
  • Wong, Siew Yee

Abstract

A method of forming a titania-coated inorganic particle comprising the steps of (a) stirring a mixture of a titania precursor such as a titanium alkoxide and an inorganic particle such as a hollow glass particles in an organic solvent such as an alcohol for more than 1 h to cause adsorption of the titania precursor on the surface of the inorganic particle; and (b) adding water dropwise to the mixture under stirring to convert the titania precursor to titania which then forms a coating on the inorganic particle. A method for forming a paint formulation, a titania-coated inorganic particle, a paint formulation comprising a titania-coated inorganic particle and use of a titania-coated inorganic particle in a paint formulation is also described.

IPC Classes  ?

  • C09C 3/06 - Treatment with inorganic compounds
  • C09D 7/62 - Additives non-macromolecular inorganic modified by treatment with other compounds
  • C09D 7/40 - Additives
  • C09D 5/33 - Radiation-reflecting paints
  • C09C 1/28 - Compounds of silicon

58.

RECOMBINANT HEPARAN SULFATES

      
Application Number SG2023050373
Publication Number 2023/229537
Status In Force
Filing Date 2023-05-26
Publication Date 2023-11-30
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Yang, Yuansheng
  • Cool, Simon Mckenzie
  • Loh, Han Ping
  • Smith, Raymond Alexander Alfred

Abstract

There is provided a nucleic acid construct comprising one or more internal ribosome entry site (IRES), one or more gene of interest, and a pair of site-specific recombinase, wherein the gene of interest is a heparan sulfate variant gene, a heparan sulfate modification enzyme gene, and/or a heparan sulfate scaffold protein gene. Also disclosed are a vector, a host cell and / or cell line, recombinant heparan sulfates, methods, kits for use thereof.

IPC Classes  ?

  • C08B 37/00 - Preparation of polysaccharides not provided for in groups ; Derivatives thereof
  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof

59.

KOJI MOLD FERMENTATION PRODUCT WITH HIGH VITAMIN B CONTENT

      
Application Number JP2023019411
Publication Number 2023/228987
Status In Force
Filing Date 2023-05-24
Publication Date 2023-11-30
Owner
  • KIKKOMAN CORPORATION (Japan)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Kan Eiichiro
  • Chen Yi Hsin
  • Lianto Kartikasaridian
  • Kawashima Tadaomi
  • Chow Yvonne
  • Hermansen Christian
  • Naulchan Khongsay

Abstract

The present invention relates to a koji mold fermentation product of a cereal-derived material which has an arabinan concentration of 5 mg/g or less. The present invention also relates to a method for producing a koji mold fermentation product of a cereal-derived material, said method comprising treating the cereal-derived material with an arabinase and a cellulase and fermenting the thus treated material using koji mold.

IPC Classes  ?

  • C12P 1/02 - Preparation of compounds or compositions, not provided for in groups , by using microorganisms or enzymes; General processes for the preparation of compounds or compositions by using microorganisms or enzymes by using fungi
  • C12N 1/14 - Fungi ; Culture media therefor
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • C12N 9/42 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4-glucosidic bonds, e.g. cellulase

60.

ENZYMES AND USES IN BIOCATALYTIC HALOGENATION OF N-HETEROARYLS THEREOF

      
Application Number SG2023050347
Publication Number 2023/224560
Status In Force
Filing Date 2023-05-19
Publication Date 2023-11-23
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Lim, Yee Hwee
  • Ang, Ee Lui
  • Wong, Fong Tian
  • Peh, Guangrong
  • Tay, Song Buck

Abstract

The present disclosure concerns enzymes and their uses in biocatalytic halogenation of pyrrolic heterocycles thereof. The method of halogenating a 2', 3' and/or 5' substituted N-heteroaryl or a derivative thereof comprises contacting the N-heteroaryl or derivative thereof with a halogen and a flavin-dependent halogenase under co-enzyme regeneration conditions in order for the halogen to be substituted at a 4' position on the N-heteroaryl or derivative thereof.

IPC Classes  ?

  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12P 13/00 - Preparation of nitrogen-containing organic compounds

61.

TEAD TARGETING COMPOUNDS AND METHODS THEREOF

      
Application Number SG2023050202
Publication Number 2023/224545
Status In Force
Filing Date 2023-03-28
Publication Date 2023-11-23
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Toh, Dewei, Joel
  • Hong, Wanjin
  • Kumar, Ramesh

Abstract

The present invention relates, in general terms, to TEAD targeting compounds and 5 methods thereof.

IPC Classes  ?

  • C07D 277/46 - Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
  • C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
  • C07D 231/40 - Acylated on said nitrogen atom
  • C07D 249/06 - 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
  • A61K 31/10 - Sulfides; Sulfoxides; Sulfones
  • A61K 31/415 - 1,2-Diazoles
  • A61K 31/426 - 1,3-Thiazoles
  • A61P 35/00 - Antineoplastic agents

62.

GAS CELL AND METHOD OF FORMING THE SAME

      
Application Number 18042681
Status Pending
Filing Date 2021-07-26
First Publication Date 2023-11-16
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Chen, Weiguo
  • Lee, Lennon Yao Ting

Abstract

Various embodiments may relate to a gas cell. The gas cell may include a chamber body. The gas cell may also include a chamber lid cooperating with the chamber body to form a space. The gas cell may further include an infrared source provided in a through hole of the chamber lid such that the infrared source extends through a thickness of the chamber lid. The gas cell may additionally include a detector provided in a through hole of the chamber body. The gas cell may further include an optical chip arranged within the space such that the optical chip is between the infrared source and the detector. The gas cell may also include three O-rings.

IPC Classes  ?

  • G01N 21/3518 - Devices using gas filter correlation techniques; Devices using gas pressure modulation techniques
  • G01N 21/05 - Flow-through cuvettes

63.

NOVEL ANTI-BACTERIAL PEPTIDES DERIVED FROM DIFFERENTIATING STEM CELLS

      
Application Number SG2023050319
Publication Number 2023/219566
Status In Force
Filing Date 2023-05-08
Publication Date 2023-11-16
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Chakraborty, Smarajit
  • Ravikumar, Vikashini
  • Sugii, Shigeki

Abstract

The present disclosure provides an anti-bacterial peptide comprising ENOS or SPARCL1, or partial sequences thereof. The present disclosure also provides a conditioned cell culture media comprising the anti-bacterial peptide, wherein the conditioned cell culture media is made by culturing adipose-derived mesenchymal stem cells. The technology also relates to a method of treating infections using the peptides.

IPC Classes  ?

  • C07K 14/47 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans from vertebrates from mammals
  • C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
  • A61K 38/10 - Peptides having 12 to 20 amino acids
  • A61K 38/17 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from humans
  • A61P 31/04 - Antibacterial agents

64.

KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF

      
Application Number 18131678
Status Pending
Filing Date 2023-04-06
First Publication Date 2023-11-16
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Gan, Bong Hwa
  • Inoue, Masafumi
  • Diermayr, Veronica

Abstract

The present disclosure provides a multiplexed amplification reaction kit for identifying a subject suffering from a malignancy sensitive to treatment with an inhibitor of the Wnt signaling pathway, comprising a primer pair capable of amplifying a PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion. Also disclosed is a method of identifying sensitivity to an inhibitor of Wnt signaling in a subject suffering from a malignancy, comprising detecting the PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion with a primer pair.

IPC Classes  ?

  • C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
  • A61K 31/519 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir

65.

A FAMILY OF THERMOGELLING CATIONIC COPOLYMERS CONTAINING POLYETHYLENIMINE AND POLYPROPYLENE GLYCOL

      
Application Number SG2023050321
Publication Number 2023/219567
Status In Force
Filing Date 2023-05-09
Publication Date 2023-11-16
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Loh, Xian Jun
  • Lim, Yuan Chong Jason
  • Lin, Qianyu

Abstract

Described herein are compositions containing branched polyethylenimine and polypropylene glycol covalently bonded to the branched polyethyleneimine, where a molar ratio of the propylene glycol to the branched polyethylenimine is more than 3.35:1, and the polypropylene glycol is hydrophobic. The compositions may be used as a hydrogel and changes between a solution phase and a gel phase by changes in pH or temperature.

IPC Classes  ?

  • C08G 71/00 - Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a ureide or urethane link, otherwise than from isocyanate radicals
  • C08J 3/075 - Macromolecular gels
  • C08G 81/00 - Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
  • C08L 75/08 - Polyurethanes from polyethers
  • C08L 75/12 - Polyurethanes from compounds containing nitrogen and active hydrogen, the nitrogen atom not being part of an isocyanate group
  • C08G 73/04 - Polyamines derived from alkyleneimines
  • C08G 65/02 - Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring

66.

APPARATUS FOR OUTER WALL FOCUSING FOR HIGH VOLUME FRACTION PARTICLE MICROFILTRATION AND METHOD FOR MANUFACTURE THEREOF

      
Application Number 18195918
Status Pending
Filing Date 2023-05-10
First Publication Date 2023-11-09
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Goh, Shireen
  • Tan, Shan Mei

Abstract

An apparatus for microfiltration and a scalable method for manufacture of an inertial microfluidic device for such microfiltration apparatus are provided. The apparatus for microfiltration includes one or more inertial microfluidic devices, each including a plurality of spirals of a microfluidic channel. At least one of the inertial microfluidic devices is configured to utilize outer wall focusing for high volume fraction microfiltration of particles. The scalable method for manufacture of the inertial microfluidic device includes micromachining on a polycarbonate-based substrate a rectangular spiral microchannel having one or more input channels and a plurality of output channels configured to utilize high volume fraction outer wall focusing for microfiltration of particles.

IPC Classes  ?

  • B04B 5/10 - Centrifuges combined with other apparatus, e.g. electrostatic separators; Sets or systems of several centrifuges
  • C12M 1/00 - Apparatus for enzymology or microbiology
  • B01D 21/26 - Separation of sediment aided by centrifugal force
  • C12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
  • C12M 1/26 - Inoculator or sampler
  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01D 43/00 - Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration

67.

RIBOZYMES

      
Application Number SG2023050318
Publication Number 2023/214939
Status In Force
Filing Date 2023-05-08
Publication Date 2023-11-09
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Aw, Shiying, Sherry
  • Lim, Yu Theng, Mandy
  • Teo, Shi Jie

Abstract

There is provided a ribozyme comprising: a) one or more catalytic domains capable of switching between an active state and an inactive state; b) one or more releasable RNA segments, wherein each of said releasable RNA segments is flanked by two ribozyme cleavage sites, wherein cleavage at each cleavage site is catalysed by at least one of the one or more catalytic domains in an active state; c) one or more trigger-binding domains, each of which is for the binding of a trigger nucleic acid molecule; wherein each of the one or more catalytic domains is linked to one of the one or more trigger-binding domains; wherein the catalytic domain is in an inactive state when the trigger-binding domain linked to said catalytic domain is not bound by the trigger nucleic acid molecule, and wherein the catalytic domain is in an active state when the trigger-binding domain linked to said catalytic domain is bound by the trigger nucleic acid molecule; and wherein when both cleavage sites flanking a releasable RNA segment are cleaved when catalysed by the one or more catalytic domains, the one or more releasable RNA segment is released from the ribozyme. Also disclosed are methods of detecting presence of a trigger nucleic acid molecule in a sample, methods of detecting presence of a sequence or mutation of interest on an nucleic acid of interest in a sample, and kits comprising the ribozymes thereof.

IPC Classes  ?

  • C12N 15/11 - DNA or RNA fragments; Modified forms thereof
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12Q 1/6816 - Hybridisation assays characterised by the detection means
  • G01N 33/569 - Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses

68.

FIBRE-BASED OLEOGEL

      
Application Number 18246135
Status Pending
Filing Date 2020-09-21
First Publication Date 2023-11-09
Owner Agency for Science, Technology and Research (Singapore)
Inventor Phoon, Pui Yeu

Abstract

The present invention relates to a method for the manufacture of an oleogel, comprising a) homogenising an aqueous dispersion of natural food fibre to develop viscosity, b) shear-mixing the aqueous fibre dispersion with liquid edible oil at room temperature to form an emulsion, and c) subjecting the emulsion to freeze-drying to remove the water. In some embodiments, the natural food fibre is citrus fibre or nata de coco fibre mix. The invention further relates to an edible fibre-based oleogel obtained by the method, as well as food products comprising the oleogel and/or based upon the oleogel.

IPC Classes  ?

  • A23D 9/04 - Working-up
  • A23D 9/007 - Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
  • A23D 7/005 - Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides

69.

COMPOUNDS FOR TREATING TUBERCULOSIS

      
Application Number 17780235
Status Pending
Filing Date 2020-11-26
First Publication Date 2023-11-02
Owner
  • NANYANG TECHNOLOGICAL UNIVERSITY (Singapore)
  • AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Gruber, Gerhard
  • Bates, Roderick Wayland
  • Ng, Shuyi Pearly

Abstract

The invention concerns a compound of formula (Ia) or (lb) wherein R1 is hydrogen or a methyl group; R2 is an unsubstituted or substituted alkyl group; R3 is an aryl group or a heteroaryl group, optionally substituted by one or more groups selected from halogen, alkyl or alkoxy; and, in Formula (Ia), X is CH or N and Y is NH, S or O, or, in Formula (Ib), X is NH, S or O and Y is CH or N. The invention further concerns a method of synthesizing the inventive compound, a composition comprising the inventive compound or a pharmaceutically acceptable salt thereof and bedaquiline (BDQ), an analogue of bedaquiline (BDQ) or a mixture thereof, and the use of said composition or compound for the treatment of tuberculosis. The invention concerns a compound of formula (Ia) or (lb) wherein R1 is hydrogen or a methyl group; R2 is an unsubstituted or substituted alkyl group; R3 is an aryl group or a heteroaryl group, optionally substituted by one or more groups selected from halogen, alkyl or alkoxy; and, in Formula (Ia), X is CH or N and Y is NH, S or O, or, in Formula (Ib), X is NH, S or O and Y is CH or N. The invention further concerns a method of synthesizing the inventive compound, a composition comprising the inventive compound or a pharmaceutically acceptable salt thereof and bedaquiline (BDQ), an analogue of bedaquiline (BDQ) or a mixture thereof, and the use of said composition or compound for the treatment of tuberculosis.

IPC Classes  ?

  • C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
  • A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
  • A61K 31/506 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • A61P 31/06 - Antibacterial agents for tuberculosis

70.

Neurosynaptic Processing Core with Spike Time Dependent Plasticity (STDP) Learning For a Spiking Neural Network

      
Application Number 18042718
Status Pending
Filing Date 2020-08-31
First Publication Date 2023-11-02
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wong, Ming Ming
  • Shrestha, Sumit Bam
  • Paramasivam, Vishnu
  • Mani, Aarthy
  • Jiang, Wenyu
  • Do, Anh Tuan

Abstract

There is provided a neurosynaptic processing core with spike time dependent plasticity (STDP) learning for a spiking neural network, including: a spiking neuron block including a pre-synaptic block and a post-synaptic block; a synapse block communicatively coupled to the spiking neuron block; a STDP learning block communicatively coupled to the spiking neuron block and the synapse block, the STDP learning block including a pre-synaptic event accumulator including a pre-synaptic spike event memory block and a pre-synaptic spike parameter modifier; a post-synaptic event accumulator including a post-synaptic spike event memory block and a post-synaptic spike parameter modifier, a weight change accumulator, and a weight change parameter modifier; a learning error modulator; and a synaptic weight modifier configured to modify a synaptic weight parameter based on a weight change parameter and a learning error corresponding to the synaptic weight parameter. There is also provided a corresponding method of operating and a corresponding method of forming the neurosynaptic processing core.

IPC Classes  ?

  • G06N 3/088 - Non-supervised learning, e.g. competitive learning
  • G06N 3/049 - Temporal neural networks, e.g. delay elements, oscillating neurons or pulsed inputs

71.

CLOSURE FOR A SAMPLE TUBE

      
Application Number 18245267
Status Pending
Filing Date 2021-09-13
First Publication Date 2023-11-02
Owner Agency for Science, Technology and Research (Singapore)
Inventor Beh, Cyrus Weijie

Abstract

A closure for a sample tube comprises a reaction vessel. The reaction vessel comprises: at least one microfluidic mixing channel having an inlet and an outlet; at least one reaction chamber in fluid communication with the inlet and the outlet; an inlet chamber proximate the inlet of the at least one microfluidic mixing channel for introducing a portion of a sample solution from the sample tube into the at least one reaction chamber under hydrostatic pressure; and a diffusion-control feature for limiting egress of fluid from the outlet such that the portion of the sample solution introduced to the at least one reaction chamber is partitioned from the rest of the sample solution.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers

72.

METHOD OF PROGNOSING AND TREATING GLIOMA

      
Application Number SG2023050192
Publication Number 2023/211366
Status In Force
Filing Date 2023-03-23
Publication Date 2023-11-02
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wu, Lele
  • Tergaonkar, Vinay

Abstract

The present invention relates to a method comprising the detection of LOC105375914 RNA in a glioma sample obtained from a subject, wherein an elevated level of LOC105375914 RNA as compared to a reference indicates that the subject has a high grade glioma, has a likelihood of resistance to chemotherapy, has a likelihood of recurrence, and/or is likely to have a poor prognosis. The present invention also relates to a method of treating a glioma expressing LOC105375914 RNA in a subject by administering an inhibitor of the LOC-DEAH-box helicase 15 (DHX15) complex to the subject.

IPC Classes  ?

  • C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
  • A61K 31/404 - Indoles, e.g. pindolol
  • A61P 35/00 - Antineoplastic agents

73.

HYALURONIC ACID-BASED SYNTHETIC COPOLYMER, MATERIAL CONTAINING SAID COPOLYMER AND RELATED METHODS THEREOF

      
Application Number SG2023050288
Publication Number 2023/211384
Status In Force
Filing Date 2023-04-26
Publication Date 2023-11-02
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Park, Eun Ju
  • Teo, Peili
  • Teo, Yew Chin

Abstract

There is provided a regenerative material for skin, bone and/or cartilage tissue regeneration, the material comprising, a hyaluronic acid-based synthetic copolymer having one or more repeating units represented by general formula (Vlll-a). Also provided are a medical device comprising said regenerative material, medical uses of said regenerative material, hyaluronic acid-based macromolecule, and a method of preparing said hyaluronic acid-based macromolecule.

IPC Classes  ?

  • C08G 61/12 - Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
  • C08L 65/00 - Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Compositions of derivatives of such polymers
  • A61K 47/30 - Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K 31/728 - Hyaluronic acid
  • A61L 15/26 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
  • A61L 15/28 - Polysaccharides or their derivatives

74.

FLUORESCENT COMPOUNDS SPECIFIC FOR PLURIPOTENT STEM CELLS AND REPROGRAMMING-READY CELLS AND METHODS OF USING THE SAME

      
Application Number 18182332
Status Pending
Filing Date 2023-03-11
First Publication Date 2023-10-26
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Sriram, Sandhya
  • Sugii, Shigeki
  • Chang, Young Tae
  • Kang, Nam-Young

Abstract

Determining, in a sample, the presence and/or amount of pluripotent stem cells. A sample suspected of containing one or more pluripotent stem cells is provided. The sample with a fluorescent compound is contacted under conditions that allow binding of the fluorescent compound to the pluripotent stem cells, where the fluorescent compound is a fluorescent compound of formula (I) or a pharmaceutically acceptable salt thereof. The presence and/or amount of the pluripotent stem cells is determined by measuring the fluorescence of the cells following the contacting.

IPC Classes  ?

  • C07F 5/02 - Boron compounds
  • C12N 5/0735 - Embryonic stem cells; Embryonic germ cells
  • C12N 5/074 - Adult stem cells
  • G01N 33/58 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

75.

CERAMIC MEMBRANE TECHNOLOGY FOR MOLECULE-RANGE SEPARATION

      
Application Number 17924298
Status Pending
Filing Date 2021-05-12
First Publication Date 2023-10-26
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Dong, Xuecheng
  • Saw, Eng Toon
  • Ang, Kun Liang
  • He, Wei

Abstract

A method of producing a silicalite membrane, which includes heating an aqueous solution that includes a dopant precursor and structure-directing template agents to form silicalite seeds incorporated with a dopant, depositing a buffer layer on a ceramic substrate prior to depositing the silicalite seeds on the buffer layer, contacting the ceramic substrate with a solution including the silicalite seeds to form a silicalite layer from the silicalite seeds on the ceramic substrate, and removing the structure-directing template agents to form the silicalite membrane, where the silicalite layer includes silicalite crystals incorporated with a dopant and each of the silicalite crystals has a hollow structure which forms the pores of the silicalite layer. The silicalite membrane includes a ceramic substrate having a buffer layer formed thereon, and a silicalite layer formed on the buffer layer, where the silicalite layer includes silicalite crystals incorporated with a dopant.

IPC Classes  ?

  • B01D 71/02 - Inorganic material
  • B01D 69/10 - Supported membranes; Membrane supports
  • B01D 67/00 - Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
  • B01D 69/04 - Tubular membranes

76.

POLYLYSINE POLYMERS WITH ANTIMICROBIAL AND/OR ANTICANCER ACTIVITY

      
Application Number 18333173
Status Pending
Filing Date 2023-06-12
First Publication Date 2023-10-19
Owner
  • International Business Machines Corporation (USA)
  • Agency For Science, Technology And Research (Singapore)
Inventor
  • Park, Nathaniel H.
  • Hedrick, James L.
  • Piunova, Victoria A.
  • Jones, Gavin
  • Yang, Yi Yan
  • Tan, Pang Kern Jeremy
  • Yang, Chuan
  • Alexander, Cherylette Anne

Abstract

Techniques regarding guanidinium functionalized polylysine polymers that can have antimicrobial and/or anticancer activity are provided. For example, one or more embodiments described herein can comprise a chemical composition, which can comprise a polymer comprising a molecular backbone covalently bonded to a pendent guanidinium functional group, wherein the molecular backbone can comprise a polylysine structure.

IPC Classes  ?

77.

THERAPEUTIC T CELL PRODUCT

      
Application Number EP2023059506
Publication Number 2023/198744
Status In Force
Filing Date 2023-04-12
Publication Date 2023-10-19
Owner
  • TESSA THERAPEUTICS LTD. (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • CLEGG, Richard Ian (United Kingdom)
Inventor
  • Teo, Pei Yun
  • Low, Lionel Jianrong
  • Jung, Youngrock

Abstract

Immune cells comprising modification to increase the expression or activity of SERPINB9 are disclosed. Also disclosed are compositions comprising such cells and methods of using such cells and compositions.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C07K 14/00 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K 14/81 - Protease inhibitors

78.

FLUID EXTRACTION APPARATUS AND METHODS OF FORMING AND OPERATING THE SAME

      
Application Number SG2022050210
Publication Number 2023/200392
Status In Force
Filing Date 2022-04-12
Publication Date 2023-10-19
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor Ooi, Yau Yen

Abstract

Various embodiments may relate to a fluid extraction apparatus. The fluid extraction apparatus may include a syringe holder configured to hold one or more syringes, and a first linear actuator configured to move the syringe holder into a position for loading of a syringe of the one or more syringes. The fluid extraction apparatus may also include a stand, a rotary platform on the stand, and a vial holder on the rotary platform. The fluid extraction apparatus may also include a cap gripper on the rotary platform, a rotary actuator configured to rotate the rotary platform between a first configuration and a second configuration, a second linear actuator configured to actuate a plunger of the syringe such that the syringe extracts at least the portion of the fluid, and a controller configured to control the first linear actuator, the second linear actuator, and the rotary actuator.

IPC Classes  ?

  • B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars

79.

OPTICAL SYSTEM, METHODS OF FORMING AND OPERATING THE SAME

      
Application Number 18024873
Status Pending
Filing Date 2021-09-15
First Publication Date 2023-10-19
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Dev, Kapil
  • Zhang, Ruochong
  • Wong, Chi Lok
  • Zhang, Shuyan
  • Unnimadhava Kurup Soudamini Amma, Dinish
  • Olivo, Malini Carolene Devapiriyai

Abstract

An optical system for imaging. The optical system includes light emitting diodes to provide light of predetermined wavelengths. The optical system further includes a charge-coupled device to receive the light emitted by one or more light emitting diodes and reflected by an object for fluorescence imaging of the object. The optical system additionally includes a broadband light source to provide broadband light. Furthermore, the optical system includes a spectrometer to receive the broadband light emitted by the broadband light source and reflected by the object for visible-near infrared-shortwave infrared spectroscopy of the object. Additionally, the optical system includes a hyperspectral camera to receive the broadband light emitted by the broadband light source and reflected by the object for hyperspectral imaging of the object as well as a controller coupled to the light emitting diodes, the broadband light source, the charge-coupled device, the spectrometer and the hyperspectral camera.

IPC Classes  ?

  • G01N 21/3563 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solids; Preparation of samples therefor
  • G01N 21/64 - Fluorescence; Phosphorescence
  • G01N 21/84 - Systems specially adapted for particular applications
  • G01N 21/359 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light

80.

ELECTRO-OPTIC MODULATOR AND METHOD OF FORMING THE SAME

      
Application Number 18041913
Status Pending
Filing Date 2021-06-25
First Publication Date 2023-10-19
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Zhu, Shiyang
  • Zhong, Qize

Abstract

Various embodiments may relate to an electro-optic modulator. The electro-optic modulator may include a waveguide configured to carry optical light along a longitudinal length of the waveguide. The electro-optic modulator may also include a first electrically conductive sub-wavelength grating on a first side of the waveguide, the first electrically conductive sub-wavelength grating including a plurality of fingers extending substantially perpendicular to the longitudinal length of the waveguide. The electro-optic modulator may further include a second electrically conductive sub-wavelength grating on a second side of the waveguide opposite the first side, the second electrically conductive sub-wavelength grating including a plurality of fingers extending substantially perpendicular to the longitudinal length of the waveguide. The electro-optic modulator may be configured to modulate the optical light upon application of a potential difference between the first electrically conductive sub-wavelength grating and the second electrically conductive sub-wavelength grating based on Pockels effect.

IPC Classes  ?

  • G02F 1/035 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on ceramics or electro-optical crystals, e.g. exhibiting Pockels or Kerr effect in an optical waveguide structure
  • G02F 1/21 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour by interference

81.

A SKIN MICROBE SAMPLER AND RELATED METHODS

      
Application Number 17926714
Status Pending
Filing Date 2021-06-11
First Publication Date 2023-10-12
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Liang, Kun
  • Leong, Kit Mun Cheryl

Abstract

The invention relates to a skin microbe sampler comprising: a plurality of solid microneedles extending from a support surface, wherein the microneedles are dimensioned to penetrate the epidermis and/or dermis layer of the skin to obtain microbes residing in the skin. In particular, in one embodiment, the microneedles comprise a cone shape that is substantially devoid of patterning on the surface of said cone shape, in another embodiment, the surfaces of the microneedles comprise an adhesion coating on their surfaces for enhancing adhesion of the microbes on the microneedles. Also provided are a method of sampling microbes residing in a skin, a method of making the microbe sampler, and a mold for making the microbe sampler. In particular, in one embodiment, the method of making the microbe sampler comprises 3D printing the solid microneedles and/or molding the solid microneedles from a negative imprint of the solid microneedles.

IPC Classes  ?

  • A61B 10/02 - Instruments for taking cell samples or for biopsy
  • B29C 33/42 - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING - Details thereof or accessories therefor characterised by the shape of the moulding surface, e.g. ribs or grooves
  • B33Y 80/00 - Products made by additive manufacturing

82.

CRISPR-BASED METHODS FOR THE DETECTION OF NUCLEIC ACIDS IN A SAMPLE

      
Application Number 18003126
Status Pending
Filing Date 2021-06-25
First Publication Date 2023-10-12
Owner
  • Nanyang Technological University (Singapore)
  • Agency for Science, Technology and Research (Singapore)
Inventor
  • Tan, Meng How
  • Ooi, Kean Hean
  • Tay, Jie Wen Douglas
  • Teo, Seok Yee

Abstract

The present invention is in the field of molecular diagnostics and is directed to the detection of target nucleic acids in a sample using a modified CRISPR-Dx system, typically with prior amplification of the target. The modified CRISPR-Dx system comprising an engineered E174R/S542R/K548R variant of AsCas12a, wherein when get activated indiscriminately cleaves at least one detection reagent to generate signal. In one embodiment, the target nucleic acid is SARS-CoV-2 RNA.

IPC Classes  ?

  • C12Q 1/6844 - Nucleic acid amplification reactions
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
  • C12Q 1/70 - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

83.

MEDICAL IMAGE PROCESSING METHODS AND SYSTEMS FOR ANALYSIS OF CORONARY ARTERY STENOSES

      
Application Number 18023108
Status Pending
Filing Date 2021-08-26
First Publication Date 2023-10-12
Owner
  • Singapore Health Services Pte Ltd (Singapore)
  • Agency For Science, Technology And Research (Singapore)
Inventor
  • Zhong, Liang
  • Huang, Weimin
  • Zhang, Junmei
  • Chandola, Gaurav
  • Lim, Soo Teik
  • Tan, Ru San
  • Tan, Swee Yaw

Abstract

Methods and systems for simulating a stent in a coronary artery lumen structure are disclosed. A method of simulating a stent in a coronary artery lumen structure, the method comprises: reconstructing a three-dimensional coronary artery tree from segmented coronary lumen contours; replacing part of the three-dimensional artery tree with a candidate stent structure; and simulating pressure distribution through the coronary artery tree to determine a non-invasive fractional flow reserve through the candidate stent structure.

IPC Classes  ?

  • G06T 7/10 - Segmentation; Edge detection
  • G06T 7/62 - Analysis of geometric attributes of area, perimeter, diameter or volume
  • G06T 7/64 - Analysis of geometric attributes of convexity or concavity
  • G06T 7/66 - Analysis of geometric attributes of image moments or centre of gravity
  • G06V 10/46 - Descriptors for shape, contour or point-related descriptors, e.g. scale invariant feature transform [SIFT] or bags of words [BoW]; Salient regional features
  • G06T 17/00 - 3D modelling for computer graphics
  • G06T 7/00 - Image analysis

84.

COMPOSITION COMPRISING A SLURRY OF CAPSULES AND METHODS THEREOF

      
Application Number 17718802
Status Pending
Filing Date 2022-04-12
First Publication Date 2023-10-12
Owner
  • Agency for Science, Technology and Research (Singapore)
  • NIPO International Pte. Ltd. (Singapore)
Inventor
  • Thoniyot, Praveen
  • Dong, Sam Siming
  • Eng, Yi Jie
  • Tan, Steve
  • Khoo, Amanda

Abstract

There is provided a composition comprising a slurry of capsules, the capsules having shells comprising silica and said shells encapsulating phase change materials (PCM); and a cementitious binder. There is also provided a method for preparing said composition.

IPC Classes  ?

  • C09K 5/02 - Materials undergoing a change of physical state when used
  • C04B 22/06 - Oxides; Hydroxides
  • C04B 24/04 - Carboxylic acids; Salts, anhydrides or esters thereof
  • B01J 13/04 - Making microcapsules or microballoons by physical processes, e.g. drying, spraying
  • C04B 24/38 - Polysaccharides or derivatives thereof

85.

METHOD AND SYSTEM FOR FACILITATING ANALYSIS OF A SKIN CONDITION

      
Application Number SG2023050228
Publication Number 2023/195924
Status In Force
Filing Date 2023-04-04
Publication Date 2023-10-12
Owner
  • EYRIS PTE LTD (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NATIONAL SKIN CENTRE (SINGAPORE) PTE LTD (Singapore)
Inventor
  • Tey, Hong Liang
  • Tan, Siyun Lucinda
  • Ong, Ee Ping
  • Ruchir, Srivastava

Abstract

Methods and systems for facilitating analysis of a skin condition are provided. The methods apply a deep neural network (DNN) to a digital skin image to identify or prepare a digital lesion skin image for further processing. Further processing can involve calculating an asymmetry (A) score based on a feature vector produced by combining feature vectors derived from the digital lesion skin image, calculating a border score based on the regularity of a lesion or skin condition, calculating a colour score based on colours detected in the digital lesion skin image, calculating a dermatoscopic score based on a presence of dermatoscopic features or structures in a digital skin lesion image, and finally calculating a final score based on the asymmetry, border, colour and dermatoscopic scores, the final score indicating a likelihood of the skin condition.

IPC Classes  ?

  • A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
  • G06V 10/25 - Determination of region of interest [ROI] or a volume of interest [VOI]
  • G06V 10/28 - Quantising the image, e.g. histogram thresholding for discrimination between background and foreground patterns
  • G06V 10/46 - Descriptors for shape, contour or point-related descriptors, e.g. scale invariant feature transform [SIFT] or bags of words [BoW]; Salient regional features
  • G06V 10/56 - Extraction of image or video features relating to colour

86.

COMPOSITE COATING MATERIAL FOR PASSIVE VIBRATION DAMPING

      
Application Number 18022975
Status Pending
Filing Date 2021-08-04
First Publication Date 2023-10-12
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Yao, Kui
  • Liew, Siao Li
  • Chen, Shuting
  • Tan, Sze Yu
  • Salloum, Rogério
  • Yan, Hong
  • Zhang, Lei
  • Lai, Szu Cheng

Abstract

A composite coating material for passive vibration damping is provided. The composite coating material includes a polymer matrix, and a piezoelectric ceramic filler and an electrically conductive filler dispersed in the polymer matrix. Particles of the piezoelectric ceramic filler have an average particle size of greater than about 100 microns (μm).

IPC Classes  ?

  • G10K 11/165 - Particles in a matrix
  • C09D 7/61 - Additives non-macromolecular inorganic
  • C09D 7/40 - Additives
  • C09D 5/24 - Electrically-conducting paints
  • C09D 163/00 - Coating compositions based on epoxy resins; Coating compositions based on derivatives of epoxy resins
  • C09D 137/00 - Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a heterocyclic ring containing oxygen; Coating compositions based on derivatives of such polymers
  • C09D 123/08 - Copolymers of ethene
  • C09D 113/00 - Coating compositions based on rubbers containing carboxyl groups

87.

POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF

      
Application Number 18044268
Status Pending
Filing Date 2021-10-21
First Publication Date 2023-10-12
Owner Agency for Science, Technology and Research (Singapore)
Inventor
  • Jana, Satyasankar
  • Seayad, Jayasree
  • Seayad, Abdul Majeed
  • Choong, Ping Sen

Abstract

There is provided a polymer or derivative thereof comprising a plurality of active amine groups in the backbone, wherein the polymer is a reaction product of a reaction between one or more bis-carbonates and one or more amine compounds having at least two terminal amino groups. Also provided are use of the polymer or derivative thereof and a method of preparing the polymer or derivative thereof.

IPC Classes  ?

  • C08G 71/04 - Polyurethanes
  • C11D 11/00 - Special methods for preparing compositions containing mixtures of detergents
  • C11D 3/00 - Other compounding ingredients of detergent compositions covered in group
  • C11D 3/37 - Polymers
  • C10M 149/14 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds a condensation reaction being involved
  • A01N 47/12 - Carbamic acid derivatives, i.e. containing the group —O—CO—N; Thio-analogues thereof containing a —O—CO—N group, or a thio-analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
  • A01P 1/00 - Disinfectants; Antimicrobial compounds or mixtures thereof
  • B01D 53/62 - Carbon oxides
  • B01D 53/78 - Liquid phase processes with gas-liquid contact
  • B01D 53/14 - Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases or aerosols by absorption

88.

COMPOUND SCREENING AND THERAPEUTIC USES

      
Application Number SG2023050227
Publication Number 2023/195923
Status In Force
Filing Date 2023-04-04
Publication Date 2023-10-12
Owner
  • SINGAPORE HEALTH SERVICES PTE LTD (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • NATIONAL UNIVERSITY OF SINGAPORE (Singapore)
Inventor
  • Hong, Jing Han
  • Tan, Jing
  • Teh, Bin Tean

Abstract

Disclosed herein a method of treating a BAP1 -related tumour in a subject, the method comprising determining whether BAP1 in the sample is functional or non-functional, and administering to the subject a therapeutically effective amount of a PARP inhibitor and a LSD1 inhibitor if BAP1 in the sample is non-functional. Also disclosed herein is a method screening and identifying an anti-proliferative compound, the method comprising obtaining a population of BAP1-deficient cells, treating said BAP1 -deficient cell population with the anti-proliferative compound, and determining a change in proliferative activity of the population of BAP1 -deficient cells compared to a population of cells producing functional BAP1 protein.

IPC Classes  ?

  • A61K 31/5375 - 1,4-Oxazines, e.g. morpholine
  • A61K 31/495 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
  • A61K 31/502 - Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
  • A61P 35/00 - Antineoplastic agents
  • G01N 33/574 - Immunoassay; Biospecific binding assay; Materials therefor for cancer

89.

VECTOR FOR GENERATING A CIRCULAR RNA

      
Application Number SG2023050238
Publication Number 2023/195930
Status In Force
Filing Date 2023-04-06
Publication Date 2023-10-12
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Wan, Yue
  • Liao, Kuo Chieh
  • Gao, Xiang

Abstract

The invention relates to generally to the field of molecular biology. In particular, the invention is directed to a vector for generating a circular RNA. Methods for generating circular RNA from a precursor RNA transcribed from the vector are also provided herein.

IPC Classes  ?

  • C12N 15/115 - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith
  • C12N 15/64 - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

90.

Method of Determining and Treating Breast Cancer

      
Application Number 17713143
Status Pending
Filing Date 2022-04-04
First Publication Date 2023-10-05
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • Singapore Health Services Pte Ltd (Singapore)
  • National University Hospital (Singapore) Pte Ltd (Singapore)
  • Tan Tock Seng Hospital Pte Ltd (Singapore)
  • MiRXES Lab Pte. Ltd. (Singapore)
Inventor
  • Lee-Lim, Siew Gek
  • Zou, Ruiyang
  • Zhou, Lihan
  • Cheng, He
  • Hartman, Bo Anders Mikael
  • Too, Heng-Phon

Abstract

This technology relates to a method of treating breast cancer in a subject and a method of determining whether a breast lesion in a subject is malignant or benign using miRNA panels.

IPC Classes  ?

  • C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

91.

METHOD

      
Application Number SG2023050142
Publication Number 2023/191709
Status In Force
Filing Date 2023-03-07
Publication Date 2023-10-05
Owner
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
  • PANTHERA LABS PTE. LTD. (Singapore)
Inventor
  • Teo, Kee Keong Adrian
  • Tan, Lay Shuen
  • Chen, Juin Ting
  • Lim, Kah Meng

Abstract

The present invention relates generally to the field of pluripotent stem cell. In particular, the invention relates to a serum- free method for differentiating pluripotent stem cells into multipotent mesenchymal stem cells (MSCs). The invention also relates to serum-free composition for differentiating pluripotent stem cells into multipotent MSCs, the composition comprising Dulbecco's Modified Eagle Medium (DMEM), KnockOut™ serum (KOSR), and GlutaMAX.

IPC Classes  ?

  • C12N 5/0775 - Mesenchymal stem cells; Adipose-tissue derived stem cells
  • C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues

92.

A METHOD AND SYSTEM FOR NAVIGATING A ROBOT IN A DESIGNATED ENVIRONMENT

      
Application Number SG2023050197
Publication Number 2023/191715
Status In Force
Filing Date 2023-03-24
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Li, Jun
  • Li, Zhengguo
  • Wan, Kong Wah
  • Chan, Chee Leong, Raymond
  • Yau, Wei Yun

Abstract

A method and system for navigating a robot 100 in a designated environment are provided herein. In an embodiment, the method comprises: selectively identifying reference features from a scale plan of the designated environment; generating a topometric map 178 of the designated environment, the topometric map 178 being associated with the identified reference features; generating an initial navigation path 176 of a local region 174 from the topometric map 178; as the robot 100 navigates along the initial navigation path 176 of the local region 174, detecting on-site reference features of the local region 174 that correspond to the identified reference features of the scale plan; and updating the topometric map 178 based on the correspondence to generate a regional path plan 188 to guide the robot's direction in the local region 174.

IPC Classes  ?

  • G01C 21/30 - Map- or contour-matching
  • G05D 1/02 - Control of position or course in two dimensions

93.

METHOD AND SYSTEM FOR LOCALISING A ROBOT USING A SCALE PLAN OF A DESIGNATED ENVIRONMENT

      
Application Number SG2023050207
Publication Number 2023/191719
Status In Force
Filing Date 2023-03-29
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Chan, Chee Leong Raymond
  • Li, Jun
  • Chan, Jian Le
  • Li, Zhengguo
  • Wan, Kong Wah

Abstract

Method and system for localising a robot 100 using a scale plan of a designated environment are provided herein. In an embodiment, the method comprises: identifying reference features from the scale plan 136; generating a predicted pose 156 of the robot's current location on the scale plan 136 based on the identified reference features; scanning on-site reference features 186 of the current location; generating a map 158 for the current location to localise the robot 100, based on the scanned on-site reference features 186 of the current location and last N frames of historical scans of previous on-site reference features 186 of a plurality of locations in the designated environment that the robot traversed through before reaching the current location; the last N frames being fewer than total frames of the historical scans of the previous on-site reference features 186.

IPC Classes  ?

  • G01S 17/89 - Lidar systems, specially adapted for specific applications for mapping or imaging
  • G01C 21/30 - Map- or contour-matching
  • G16Y 40/60 - Positioning; Navigation

94.

CHEMICAL SENSOR AND METHOD OF FORMING THE SAME

      
Application Number 17928445
Status Pending
Filing Date 2020-06-01
First Publication Date 2023-10-05
Owner Agency for Science, Technology and Research (Singapore)
Inventor Lee, Lennon Yao Ting

Abstract

A chemical sensor that includes a first semiconductor substrate. The chemical sensor may also include a second semiconductor substrate. The chemical sensor may further include one or more metal layers between the first semiconductor substrate and the second semiconductor substrate such that the first and second semiconductor substrates and the one or more metal layers form a cell including a cavity, the cavity having a depth of any value equal to or less than 100 μm. The chemical sensor may also include an optical source. The chemical sensor may additionally include an optical detector such that light emitted by the optical source passes through the cell to the optical detector. The first and second semiconductor substrates and the one or more metal layers may also define at least one inlet for fluid to flow into the cavity and at least one outlet for fluid to flow out of the cavity.

IPC Classes  ?

  • H01L 25/16 - Assemblies consisting of a plurality of individual semiconductor or other solid state devices the devices being of types provided for in two or more different main groups of groups , or in a single subclass of , , e.g. forming hybrid circuits
  • G01N 21/61 - Non-dispersive gas analysers
  • H01L 23/00 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details of semiconductor or other solid state devices

95.

AN IMPLANT, A DEPLOYER TOOL FOR INSERTING AN IMPLANT, AND A SYSTEM FOR FACILITATING THE CONDUCTION OF FLUID

      
Application Number SG2022050178
Publication Number 2023/191702
Status In Force
Filing Date 2022-03-30
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Chen, Tao Yi David
  • Hee, Jia Yun
  • Ho, Shihan Bryan
  • Mohan, Preeti

Abstract

There is provided an implant configured to be deployed in an eye by a deployer tool to facilitate conduction of fluid from a posterior chamber to a suprachoroidal space of the eye, the implant comprising, an elongate member having a proximal segment configured to be disposed in the posterior chamber of the eye and a distal segment configured to be disposed in the suprachoroidal space of the eye, wherein the elongate member is configured to maintain a bent configuration that substantially complies with anatomical curvatures of the posterior chamber and the suprachoroidal space, when deployed in the eye. There is also provided a deployer tool for inserting an implant as disclosed herein into an eye to facilitate conduction of fluid from a posterior chamber to a suprachoroidal space of the eye, and a system for facilitating the conduction of fluid from a posterior chamber to a suprachoroidal space of an eye.

IPC Classes  ?

96.

METHODS AND SYSTEMS FOR TRACKING LIVING OBJECTS

      
Application Number SG2023050208
Publication Number 2023/191720
Status In Force
Filing Date 2023-03-29
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Ma, Yugang
  • Jin, Bo
  • Sun, Sumei
  • Zeng, Yonghong
  • Zhong, Zhigang

Abstract

A method for tracking one or more living objects using at least one processor is provided. The method includes: receiving, via a plurality of receiving antennas, signals transmitted from a plurality of transmitting antennas; identifying a location of each of the one or more living objects with respect to a discrete time based on the signals received in a number of a sampling periods; determining a movement of each of the one or more living objects based on the identified location; determining one or more vital signs of each of the one or more living objects based on the movement of each of the one or more living objects; and tracking collectively the location and the one or more vital signs of each of the one or more living objects.

IPC Classes  ?

  • A61B 5/05 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
  • G01S 13/36 - Systems for measuring distance only using transmission of continuous waves, whether amplitude-, frequency-, or phase-modulated, or unmodulated with phase comparison between the received signal and the contemporaneously transmitted signal
  • A61B 5/024 - Measuring pulse rate or heart rate
  • A61B 5/113 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb occurring during breathing

97.

METHOD AND SYSTEM FOR NAVIGATING A ROBOT

      
Application Number SG2023050213
Publication Number 2023/191723
Status In Force
Filing Date 2023-03-30
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Leong, Jiacheng, Andrew
  • Adiwahono, Albertus, Hendrawan
  • You, Yangwei
  • Chuah, Meng Yee
  • Chen, Tai Pang
  • Chan, Jian Le
  • Chan, Chee Leong, Raymond
  • Ng, Kam Pheng
  • Wan, Kong Wah
  • Yau, Wei Yun

Abstract

A method and system for navigating a robot 100 are provided herein. In an embodiment, the method comprises: detecting on-site reference features of the robot's location when the robot is traversing in an environment; identifying objects of interest 180 from the detected on-site reference features; deriving a semantic data for each object of interest 180 from the on-site reference features; generating a semantic cost map 166 based on the semantic data of the objects of interest 180, the semantic cost map 166 representing cost of traversing in the environment; and navigating the robot 100 based on the semantic cost map 166.

IPC Classes  ?

  • G05D 1/02 - Control of position or course in two dimensions
  • G01C 21/00 - Navigation; Navigational instruments not provided for in groups
  • G06V 20/58 - Recognition of moving objects or obstacles, e.g. vehicles or pedestrians; Recognition of traffic objects, e.g. traffic signs, traffic lights or roads

98.

ANTI-TUBERCULAR COMPOSITIONS

      
Application Number SG2023050218
Publication Number 2023/191725
Status In Force
Filing Date 2023-03-31
Publication Date 2023-10-05
Owner
  • NANYANG TECHNOLOGICAL UNIVERSITY (Singapore)
  • AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Grűber, Gerhard
  • Bates, Roderick Wayland
  • Ng, Shuyi Pearly

Abstract

Disclosed herein is a combination that includes a F1F0-ATP synthase inhibitor or a pharmaceutically acceptable salt or solvate thereof that selectively binds to the F1 domain of the F1F0-ATP synthase in combination with one or more of the compounds selected from: (a) an NADH dehydrogenase inhibitor or a pharmaceutically acceptable salt or solvate thereof; (b) a cytochrome-bcc:aa3 inhibitor or a pharmaceutically acceptable salt or solvate thereof; and (c) a F1F0-ATP synthase inhibitor or a pharmaceutically acceptable salt or solvate thereof that selectively binds to the F0 domain of the F1F0-ATP synthase.

IPC Classes  ?

  • A61P 31/06 - Antibacterial agents for tuberculosis
  • A61K 31/506 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • A61K 31/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
  • A61K 31/451 - Non-condensed piperidines, e.g. piperocaine having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
  • A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

99.

A SYSTEM AND METHOD OF DETECTING A DIRECTION OF ARRIVAL OF ONE OR MORE TARGET SIGNALS USING AN ANTENNA ARRAY

      
Application Number SG2023050221
Publication Number 2023/191728
Status In Force
Filing Date 2023-03-31
Publication Date 2023-10-05
Owner AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (Singapore)
Inventor
  • Tang, Xinyi
  • Qing, Xianming

Abstract

There is provided a system and method of detecting a direction of arrival of one or more target signals using an antenna array, the method comprising, i) generating a map representing a ratio of a co-polarization (Co-pol) pattern received by the first beam to a cross- polarization (X-pol) pattern received by the second beam; ii) obtaining Co-pol and X-pol signal strengths of the one or more target signals received by the first and second beams in step (i); iii) obtaining the Co-pol to X-pol ratio of each of the one or more target signals; iv) normalizing the generated map; v) normalizing the Co-pol to X-pol ratios of the one or more target signals; and vi) for each target signal: finding area(s), within the normalized generated map, which substantially match the normalized Co-pol to X-pol ratio of the target signal; and identifying said area(s) of the normalized generated map as potential direction(s) of arrival of the target signal.

IPC Classes  ?

  • G01S 3/04 - Direction-finders for determining the direction from which infrasonic, sonic, ultrasonic, or electromagnetic waves, or particle emission, not having a directional significance, are being received using radio waves - Details
  • H01Q 21/24 - Combinations of antenna units polarised in different directions for transmitting or receiving circularly and elliptically polarised waves or waves linearly polarised in any direction
  • H01Q 21/06 - Arrays of individually energised antenna units similarly polarised and spaced apart

100.

WOUND HEALING MODEL

      
Application Number 18245423
Status Pending
Filing Date 2021-09-16
First Publication Date 2023-09-28
Owner
  • Agency for Science, Technology and Research (Singapore)
  • Nanyang Technological University (Singapore)
Inventor
  • Becker, David
  • Chin, Jiah Shin
  • Madden, Leigh
  • Tan, Li Ling Mandy

Abstract

The invention relates generally to the field of wound healing. In one embodiment is a method for generating a delayed wound model in an animal, the method comprising contacting a wound with a composition comprising an electrospun scaffold, wherein the scaffold is made from 80% PCL and 20% rat tail collagen and has been soaked in a biofilm conditioned media from Staphylococcus aureus or a small molecular drug FK866.

IPC Classes  ?

  • A61K 31/4545 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
  • A61L 27/24 - Collagen
  • A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
  1     2     3     ...     36        Next Page